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Sudden cardiac death (SCD) attributed to ventricular fibrillation (VF) kills 
approximately 200,000 people each year in the United States alone. Yet, the 
mechanisms responsible for VF, and therefore VF-related SCD, are incompletely 
understood. However, what is known is that during VF, spiral waves are 
generated by electrical rotors at an exceedingly high frequency, and these waves 
then propagate through the ventricles and generate turbulent activation. 
Repolarizing potassium currents, including the inward rectifier potassium current 
(IK1) and the slow component of the delayed rectifier (IKs), have been shown to 
contribute to the control of the rotor’s spinning frequency as well as to the 
complexity of turbulent propagation. However, the role of the fast component of 
delayed rectifier (IKr) in the initiation and maintainence of VF has not previously 
been investigated; as a result, this ionic current served as a major area of 
interest during my graduate studies (see below). Another area that is gaining 
attention (both at a global research level and in my own work) is the potential use 
of cellular and gene therapy in clinical treatments.  The advent of gene therapy 
has offered new hope and several tantalizing possibilities of new treatments for a 
variety of pathological conditions.  With respect to cardiac physiology and 
arrhythmogenesis, our laboratory’s goal is to use this technology to help repair 
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and/or restore function in the myocardium, which is inherently considered not to 
be a regenerative tissue/organ. Over the past years, I worked with normally non-
excitable cells (cardiac fibroblasts), genetically engineered them so that they 
could become excitable, and determined whether they could then generate and 
propagate action potentials within the myocardium. In so doing, the long-term 
goal is to integrate these genetically modified excitable fibroblasts into injured 
myocardium, with the hope that they might serve as a novel means to prevent 
arrhythmias in ischemic heart disease and/or restore impaired cardiac function in 
diseased tissue.  
  During my PhD studies in the laboratory of Dr. José Jalife at the University 
of Michigan, I focused on two major questions related to cardiac 
electrophysiology and the mechanisms of cardiac arrhythmias. First, I examined 
the ionic mechanisms of reentry. Specifically, I studied how IKr influences rotor 
behavior. The second area of my research examined whether a combination of 
cellular and gene therapy, which was aimed at reducing heterogeneous 
propagation and cardiac turbulence, could be a novel approach to treat VF. As 
discussed briefly above, this project created and used genetically modified, 
excitable cardiac fibroblasts in order to rescue normal impulse propagation and 
reduce the risk of arrhythmia initiation and maintenance.  
 
1. A major role for hERG in determining the frequency of reentry in 
neonatal rat ventricular myocyte monolayers: The rapid delayed rectifier 
potassium current, IKr, which flows through the human ether-a-go-go-related 
xvi 
 
(hERG) channel, is a major determinant of the shape and duration of the human 
cardiac action potential (AP). However, it is unknown whether the time 
dependency of IKr enables it to control the action potential duration (APD), 
conduction velocity (CV) and wavelength (WL) at the exceedingly high activation 
frequencies that are relevant to cardiac reentry and fibrillation. It was my 
hypothesis that upregulation of hERG would increase functional reentry 
frequency and contribute to its stability. Using optical mapping, I investigated the 
effects of IKr upregulation on reentry frequency, APD, CV and WL in neonatal rat 
ventricular myocyte (NRVM) monolayers overexpressing GFP (control), hERG 
(IKr), or a dominant negative mutant form of hERG, G628S. Reentry frequency 
was significantly higher in IKr-infected monolayers, and slightly reduced in 
G628S-infected monolayers. APD80 in IKr-infected monolayers was shorter 
(>50%) than in control monolayers during pacing at 1-5 Hz. The CV was similar 
in both groups at low frequency pacing. In contrast, during high frequency reentry, 
the CV measured at varying distances from the center of rotation was 
significantly faster in IKr-infected monolayers than in control. Computer 
simulations using a modified NRVM model predicted that rotor acceleration was 
due in part to a transient hyperpolarization immediately following the AP. The 
transient hyperpolarization was confirmed experimentally. These results show 
that hERG overexpression accelerates reentry frequency more than two fold in 
NRVM monolayers. Both APD and WL shortening, together with transient 
hyperpolarization, underlie the increased rotor frequency and stability. Therefore, 
while it has been traditionally thought that IKr reduction is pro-arrhythmic, our 
xvii 
 
results suggest that, given the right circumstances, increase in IKr could be a 
factor in maintaining VF.  
 
2. Genetically engineered excitable cardiac fibroblasts coupled to 
cardiomyocytes rescue normal propagation and prevent arrhythmias in 
heterocellular monolayers: The use of genetic engineering of unexcitable cells 
to enable expression of gap junctions and inward rectifier potassium channels 
has suggested that cell therapies aimed at establishing electrical coupling of 
unexcitable donor cells to host cardiomyocytes may be arrhythmogenic. Whether 
similar considerations apply when the donor cells are electrically excitable has 
not been investigated. Here I tested the hypothesis that adenoviral transfer of 
genes coding Kir2.1 (IK1), NaV1.5 (INa) and connexin-43 (Cx43) proteins into 
neonatal rat ventricular myofibroblasts (NRVF) will convert them into fully 
excitable cells, rescue rapid conduction velocity (CV) and reduce the incidence of 
complex reentry arrhythmias in an in vitro model. At varying multiplicity of 
infection (MOI) ratios of 10/10, 5/10 and 5/20, NRVF co-infected with Ad-Kir2.1 + 
NaV1.5 were hyperpolarized and generated action potentials (APs) with upstroke 
velocities >100V/s. However, when forming monolayers only the addition of Ad-
Cx43 made the excitable NRVF capable of conducting electrical impulses 
(CV=20.71±0.79cm/s). When genetically engineered excitable NRVF 
overexpressing Kir2.1, NaV1.5 and Cx43 were used to replace normal NRVF in 
heterocellular monolayers that included neonatal rat ventricular myocytes 
(NRVM), CV was significantly increased (27.59±0.76 vs. 21.18±0.65 cm/s, 
xviii 
 
p<0.05), reaching values similar to those of pure myocyte monolayers 
(27.27±0.72 cm/s, NS). Moreover, during reentry, propagation was faster and 
more organized, with a significantly lower number of wavebreaks in heterocellular 
monolayers formed by excitable compared to unexcitable NRVF. It suggested 
that viral transfer of genes coding Kir2.1, NaV1.5 and Cx43 to cardiac fibroblasts 
endows them with the ability to generate and propagate APs. These results 
supported the idea that cellular therapies with excitable donor cells increase 
safety and reduce arrhythmogenic potential. While still preliminary, these results 
provide a proof-of-concept evidence that may eventually result in new therapy to 
treat myocardial infarction, which is associated with massive death of myocytes 
and replacement by fibrosis tissue. 
 
  Therefore, it is my sincere hope that the work accomplished as part of this 
dissertation will lead to an overall better understanding of the molecular 
determinants of VF, and that it will serve as a basis for the development of cell-







1.1 Normal and Abnormal Impulse Propagation in Heart 
  The human heart beats approximately 36 million times every year [1]. Its 
function is to pump blood, and thereby provide oxygen and nutrients that are 
essential for the viability of cells throughout the body. For the heart to function 
efficiently, it is critical that atria and ventricles contract regularly and 
synchronously. Blood is pumped from atria to ventricles, and then to the rest of 
the body. During this process, arterial circulation delivers blood to vital organs, 
including the brain, kidneys, liver and skeletal muscles. Venous circulation 
returns deoxygenated blood first to the right atrium and then to the right ventricle, 
where it is pumped into the lungs for exchange of gases (i.e. blood becomes 
enriched with oxygen and loses carbon dioxide). Thereafter, the oxygenated 
blood returns to the left atrium via the pulmonary veins. The blood is then 
pumped into the left ventricle, and through the aorta to the rest of the body. This 
cycle continues thousands of times every day [2].  
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  The cardiac cycle is important because the brain is highly sensitive to 
changes in blood pressure and blood flow. For example, interruption of the 
ventricular contraction for even a few seconds can lead to a drop in blood 
pressure. Consequently, blood supply to the brain would be reduced and a loss 
of consciousness would be highly probable for the individual. Taken together, 
decreased blood pressure and blood flow to the brain could lead to brain damage, 
and even death, if normal circulation is not resumed within minutes [3]. 
  Electrical impulses are the drivers for the mechanically coordinated 
contractions in both atria and ventricles. The initiator of these electrical impulses 
is the sinoatrial node. This specialized conglomerate of intrinsically automatic 
cells in sinoatrial node serves as the primary pacemaker that maintains the 
normal rhythm responsible for each contraction of the heart. The activity of these 
synchronously beating pacemaker cells can be modulated by the autonomic 
nervous system in human, which may increase or decrease heart rate and also 
modulate contractions. The human heart rate is ~ 70 beats per minute at rest, but 
it can increase to more than 200 beats per minute during excise [4]. At the 
command of sinoatrial pacemaker impulses, all atrial myocytes will be the first to 
depolarize and contract in a coordinated way. On surface eletrocardiogram 
(ECG), which is recorded using electrodes that are attached to the skin and 
connected to a recording device, this depolarization of the atria corresponds to 
the P wave (Figure 1.1A). After the impulse travels rapidly through both atria to 
initiate their contraction, it will be delayed briefly upon reaching the 
atrioventricular (AV) node, which contains specialized, slowly conducting cells 
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that bridge the atria and ventricles. This delay, represented on ECG as the PR 
interval, is critical because it enables atiral contraction to complete prior to 
initiation of ventricular contraction which ends up closing the AV valve. Thereafter, 
the electrical impulse propagates through the His bundle and along the left and 
right bundle branches, leading to the depolarization of ventricular myocytes and 
their subsequent synchronized contraction. On ECG this process corresponds to 
the QRS complex, which is followed by the ST interval and the T wave, each 
corresponding to a consecutive phase during the slow repolarization of the 
ventricles. The cardiac cycle then repeats, with rhythmic electrical impulses 
generated repetitively by the sinoatrial pacemaker. 
Alteration in any step of the cardiac electrical impulse (as described 
above) may lead to arrhythmias. Importantly, not all cardiac arrhythmias are 
lethal, and the symptoms may be variable under different pathological conditions 
as well as in different individuals [5, 6]. While most patients are not even aware 
of an occasional irregularity of their heartbeat, others may have very severe 
symptoms. This can be illustrated with the case of premature ventricular 
complexes (PVCs). On ECG, PVCs are characterized by wide and bizarre-
looking QRS complexes that are not associated with P waves. In many patients, 
PVCs are asymptomatic [7]. However, for the majority of patients with 
symptomatic PVCs, these premature beats do not necessarily lead to a more 




Premature beats can occur in the atria as well. Atrial premature beats 
originate at regions other than the sinoatrial node. On ECG they are identified by 
premature or deformed P waves [8]. If a premature atrial beat reaches the AV 
node during its refractory period, it will be unable to reach the ventricles, and as a 
result, there will be no QRS complex associated with it. Atrial premature beats 
may be harmless in healthy patients; and, like PVCs, they can be the result of 
normal biological variability. However, when patients have structural heart 
disease, atrial premature beats can trigger severe arrhythmias like atrial flutter or 
atrial fibrillation.  
Arrhythmias can be categorized into two major types: bradyarrhythmias 
(heart rate less than 60 beats per minute) and tachyarrhythmias (heart rate 
greater than 100 beats per minute at rest) [9]. Both types of arrhythmia may 
occur in sinoatrial nodal disease (also known as sick sinus syndrome), which 
usually affects the specialized conduction system. Bradyarrhythmias may occur 
as a result of impairment of impulse generation or conduction. Heart block, also 
known as AV block, is the most common cause of bradyarrhythmia [10]. AV block 
occurs when there is an impairment of normal conduction between the atria and 
ventricles, either at the level of the AV node itself or at the level of the His-
Purkinje system. There are three degrees of AV block. First degree AV block is 
diagnosed by a prolongation of the PR interval. Characterized by a PR interval 
greater than 200 ms, first degree AV block can be the non-pathological result of 
enhanced vagal tone, which is often a consequence of intense physical training. 
On the other hand, it could also result from an acute myocardial infarction or from 
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pharmacological agents [11]. However, unlike the other two types of AV blocks, 
while the PR interval is prolonged, its duration at rest is relatively constant, and 
for each P wave, there is a subsequent QRS complex. 
 Second degree AV block is defined as one or more atrial impulses that 
fail to propagate to the ventricles [12]. On ECG this can be visualized as a P 
wave that is not followed by a QRS complex. Second degree AV block can be 
further classified as type 1 and type 2. Type 1, also known as Wenkebach 
periodicity, can be a benign response to an increase in the normal atrial 
frequency that manifests itself as increasing delays between the P wave and the 
QRS complex before the omission of one QRS complex [13]. In typical 
Wenckebach periodicity, the prolongation of the PR interval occurs with 
decreasing increments; whereas atypical Wenkebach periodicity is associated 
with progressive PR prolongation with increasing increments. Type 2 second 
degree AV block has no such pattern. Instead, AV block occurs suddenly without 
prior changes in the PR interval. Like first degree AV block, second degree AV 
block may result from pharmacological agents or diseases. However, in this case 
the alteration is usually due to abnormal conduction at the level of the His-
Purkinje system [14].  
Third degree AV block is also called complete heart block, which means 
that none of the atrial impulses conduct to the ventricles [15]. On ECG, two 
independent rhythms may be detected in association with third degree AV block. 
One rhythm is the result of atrial depolarization under the command of the SA 
node. As a result, patients with third degree AV block have regular PP intervals. 
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The other rhythm is the excitation of the ventricles initiated by the AV node. This 
generates QRS waves with variable PR intervals. Unlike the other two types of 
AV block, third degree AV block is always the result of an underlying pathology, 
with the most common cause being myocardial infarction [16].  
Tachyarrhythmias may originate in the atria or the ventricles. During atrial 
flutter, a patient’s atrial contraction rate can increase up to 240 - 433 beats per 
minute [17, 18]. On ECG atrial flutter manifests as flutter waves, which can vary 
in both the beat-to-beat amplitude and duration. As with monomorphic or 
polymorphic VT, atrial flutter can lead to atrial fibrillation. 
Atrial fibrillation (AF) is a severe type of atrial arrhythmia [19, 20]. Like 
atrial flutter, AF excites the atria at high rates: 240-360 beats per minute. On 
ECG, AF is typically characterized by the absence of P waves, which are 
replaced by disorganized electrical activity with irregular RR intervals [21]. 
VT and VF are the most severe forms of ventricular arrhythmias. 
Monomorphic VT may result from ventricular ectopic discharges or from reentry 
in the ventricles. It is characterized by an excessively rapid heart rate in the 
absence of P waves. Further, the interbeat intervals are periodic and the QRS 
complexes are identical to each other in any given ECG lead [22].  
On the other hand, polymorphic VT is distinguished by beat to beat 
variations in the amplitude and/or morphology of the QRS complex [23]. 
Torsades de pointes (TdP), which literally means twisting of the points, is the 
most well-known example of polymorphic VF. It is characterized by a waxing and 
7 
 
waning of the QRS amplitude, and it may terminate spontaneously or degenerate 
into VF [24].  
Similar to AF, both monomorphic and polymorphic VT could be the 
emsemble outcomes of underlying genetic factors, nutritional deficiencies, 
pharmacology, and/or gross structural changes to the heart anatomy that are 
most commonly brought on by myocardial infarction [20, 25, 26]. VT is life-
threatening, mostly because it has the potential to degenerate into VF, which is 
defined as turbulent cardiac electrical activity that precludes adequate pumping 
of blood. On ECG, VF is characterized by an excessively rapid (>500 QRS 
complexes/min) and irregular heart rhythm that results in uncoordinated 
contraction [27]. VF rapidly results in loss of consciousness because of cessation 
of blood circulation, and it may lead to an irreversible tissue/organ damage 
unless terminated within 10 minutes by electric shock treatment [28].  
While there are numerous types of arrhythmias, some being asymptomatic 
and others being highly symptomatic, a better understanding of the causes, 
treatments, and prevention for each can be best achieved through knowledge of 
the molecular and biophysical bases of ion channel function, which underlie the 
characteristics of the cardiac action potential. 
1.1.1 Action Potential and Ion Channels 
  To understand cardiac impulse propagation and the mechanisms of 
arrhythmias, one must first examine the excitability of a single cell. Excitability is 
a key property that underlies the ability of the electrical impulse to propagate 
from cell to cell throughout the heart [29, 30]. Similar to neurons and skeletal 
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muscle cells, cardiac myocytes are excitable cells. Unlike other cell types, 
excitable cells have a well-polarized resting membrane potential (RMP). The 
RMP is the result of electrochemical gradients, and it is established by the 
diffusion of multiple ions (e.g., Na+, K+, Cl-) across specialized membrane protein 
channels that are embedded in the cell membrane. At rest, the membrane 
potential of non-pacemaker cells remains stable at -70 to -90 mV. However, the 
ionic fluxes of sodium, calcium and potassium ions across the membrane enable 
excitable cells to generate action potentials (APs). These ionic fluxes directly 
results in a stereotypic change in the electrical potential across the cell 
membrane, which is associated with the passage of an impulse. Importantly, the 
duration of the cardiac AP is much longer (~ 200 ms) than the AP characteristic 
of  neurons and skeletal muscle cells (~1 and 10 ms, respectively) [31]. The 
temporal course of the cardiac AP is divided into five distinct phases numbered 
0-4 (Figure 1.1B). Phase 0 is initiated by depolarization to a threshold potential (~ 
-60 mV) for activation of the fast sodium inward current (INa) through voltage-
gated, cardiac-type sodium channels. Typically, the influx of positively charged 
sodium ions depolarizes the atrial or ventricular myocyte at a very high speed to 
an overshoot of the membrane potential to +30 mV. Phase 1 represents the 
quick partial repolarization that occurs immediately after peak depolarization. 
Phase 1 often appears as a notch, and this is due to the fast inactivation 
(closure) of sodium channels and the activation (opening) of the transient 
outward potassium channels (Ito). Phase 2 is called the plateau phase of the 
cardiac AP. At this phase, the membrane potential lingers transiently near 0 mV 
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and contributes to the long APD. The plateau represents the balance between 
inward currents, through L-type calcium channels (ICaL), and outward currents, 
mainly through IKr and IKs which are the rapid and slow components, respectively, 
of the delayed rectifier current [32]. With time, the slow decrease in ICa together 
with an increase in outward potassium currents tilts the balance towards further 
repolarization. During phase 3, a large outward current (IK1), provided by strong 
inward rectifier potassium channels (Kir2.x), brings the membrane potential back 
to its resting level. Phase 4 is the RMP. During this phase, the dynamic balance 
between the inward and outward movement of potassium ions through inward 
rectifier potassium channel keeps the RMP at a very negative level. Thus, IK1 is 
critical to cellular excitability: by maintaining RMP at -70 to -90 mV during rest, 
and by ensuring the availability of sodium channels for the initiation of the next 
AP [33]. In addition, a number of other ion channels also contribute to RMP in 
cardiac cells, such as sodium/potassium pump, sodium/calcium exchanger, and 
chloride channels. 
1.1.2 Ventricular Fibrillation and Sudden Cardiac Death 
  Ventricular fibrillation (VF) is the leading cause of sudden cardiac death 
(SCD), which accounts for about 200,000 fatalities annually in the United States 
alone [34]. Despite decades of research, there is no cure for VF, and the best 
long-term treatment remains the implantation of an Implantable Cardiac 
Defibrillator (ICD). Most likely, this is due to an incomplete understanding of the 
molecular mechanisms responsible for VF [34-36]. On ECG, VF is diagnosed by 
the presence of an aperiodic and irregular rhythm, which suggests that cardiac 
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activation of the ventricles is exceptionally complex and disorganized during the 
VF period (Figure 1.1C) [36]. However, modern technologies that enable high 
spatial and temporal resolution imaging as well as the complex mathematical 
modeling (computer simulations) have provided evidences to support the idea 
that VF is, in fact, deterministic, quantifiable, and mechanistically understandable 
[35, 37]. Reentry is one type of abnormal impulse propagations observed during 
fibrillation. It occurs when an electrical impulse travels in continuous loop, rather 
than propagating linearly throughout the heart. A number of experimental and 
computer simulation studies have suggested that reentry is one of the most 
important mechanisms underlying VF and SCD [38-40].  
1.1.3 Reentry and Arrhythmias 
  The first descriptions of reentry activity during VF were provided by 
MacWilliam in 1887 [41]. Three important features of “arrhythmic fibrillar 
contraction” were observed in that principal study: complexity, persistence, and 
rapidity. However, the first mechanistic insight into how VF can occur came 
twenty years later when Mayer et al. observed and described reentry activity in 
jellyfish tissues [42]. The important observation from this study was that 
unidirectional block was a prerequisite for reentry activity to occur. In 1914, 
Mines et al. further improved our understanding of arrhythmias by providing 
evidence that reentry around an obstacle was responsible for arrhythmias in dog 
cardiac tissue [43]. Subsequent works focused on what we now call “anatomical” 
reentry, which relies on a fixed barrier around which the electrical wave can 
travel [44-46]. However, as improvements in technology allowed for more precise 
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measurements of impulse propagation, it was discovered that the presence of an 
anatomical obstacle was not always a prerequisite for fibrillation. In the 1970s, 
Allessie et al were the first group to demonstrate functional reentry in rabbit atrial 
muscle [47]. In their study, Allessie et al. proposed the “leading-circle” concept, 
which was defined as a sustained wave of propagation at the “leading” tip of a 
circuit around a critical sized “circle” [47-49]. This concept was highly appreciated 
by both clinicians and experimental physiologists because it not only 
complemented our early understanding of fibrillation, but it also was a theory that 
allowed for verifiable antiarrhythmic interventions. However, subsequent 
technological breakthroughs would later allow for even more precise 
measurements and new insights. Advances in biophysics and computer 
modeling, for example, led to the concept of  “rotors” as the drivers of “spiral 
wave” reentry [50].The introduction of this principle has significantly expanded 
and improved our understanding of functional reentry as a central mechanism of 
cardiac fibrillation.  
  The idea that rotors and spiral waves could exist in the heart initially came 
from studies in other excitable media, such as a chemical reaction called the 
Belousov–Zhabotinsky reaction [51]. It was found that if the conditions were just 
right, the solution (e.g. Ferroin solution) would change color in a spiral wave 
fashion [52]. Arthur T. Winfree was one of the first theoretical biologists to use 
mathematical modeling to demonstrate that rotors could theoretically exist in the 
heart [53]. Further, using 3-D computer models of the heart, it was shown that a 
rotor of electrical impulse is a “fingerprint” of a 3-D wave called a scroll wave [36, 
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54-56]. Experimental evidence for the existence of rotors and spiral waves of 
electrical impulse in many mammalian species (mouse, guinea pig, rabbit, pig, 
sheep and human) was obtained using high temporal/spatial optical imaging on 
the surface of isolated heart by Jalife’s group and others [57-62]. Using voltage 
sensitive dyes (e.g. di-4-ANEPPS, di-8-ANEPPS) and charge-coupled device 
(CCD) cameras, optical mapping has been demonstrated to be a very powerful 
tool to visualize and study complex patterns of electrical wave propagation during 
cardiac arrhythmias [63].  
  One obstacle to current research on spiral waves and rotors is the 
limitation posed by technology. For example, investigators cannot image 3-D 
propagation of electrical wave in the ventricles with the high spatial/temporal 
resolution needed to visualize spiral waves; and, as a result, they are limited to 2-
D analysis of the heart [64, 65]. This poses a significant problem that may affect 
the interpretation of the results: Depending on the orientation of the scroll wave 
and the placement of the imaging device, one may observe a spiral wave, or see 
other complex impulse propagation patterns [66]. An indirect, but nevertheless, 
useful tool called dominant frequency (DF) mapping was therefore developed to 
infer the location of a scroll wave [67]. Using Fast Fourier Transform analysis, DF 
mapping enables to take a fluorescent signal obtained during optical mapping 
and convert it from the time domain to the frequency domain. In the frequency 
domain, the frequency with the highest amplitude (power) is called the DF; which 
likely represents the rotation frequency of the scroll wave. Therefore, if spiral 
waves are the “fingerprints” of 3-D scroll waves that underlie fibrillations, then 
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understanding the dynamics of spiral waves should enable us to better 
understand both atrial and ventricular fibrillation.  
1.1.4 Properties of Spiral Waves 
  Propagation of voltage waves through the myocardium is a complex non-
linear phenomenon. Historically, our understanding of this process began with 
the application of the classical cable theory to cardiac electrophysiology [68, 69].  
  Voltage impulse propagation can be clearly illustrated with an example of 
a very simple model: a 1-D cable of myocytes where a stimulus is applied to one 
end of the cable. It is useful to think of a propagating wave in the cable as a 
propagating AP. Phase 1 can be considered to be the wave front and phase 3 
can be considered to be the wave tail. If this AP were to propagate through the 1-
D cable, a source cell (depolarized cell) would need to provide enough 
electrotonic current through gap junctions to its neighboring cell in order to bring 
that cell’s membrane potential to the threshold for sodium channel activation. 
Once the neighboring cell generates an AP, it then becomes a source and the 
process continues as the wave propagates from cell to cell. The process of ion 
fluxes that occur below the membrane potential for sodium channel activation are 
called electrotonic interactions.   
  If the 1-D cable was replaced by a 2-D sheet, then the scenario would 
become much more complex. Consider the example of a planar wave 
propagating through a homogenous medium composed of thousands of 
electrically connected heart cells (Figure 1.2A). As the wave propagates, the 
conduction velocity (CV) can be calculated by measuring the activation time 
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between fixed points and then dividing it by the distance traveled between points. 
If, however, the wave is concave (negative curvature), then the cells at the wave 
front need to provide current to relatively fewer cells than would be required by a 
planar wave (Figure 1.2B). For a concave wave, more diffusive current is 
available to flow into the recipient cells as compared to the planar wave situation. 
As a result, the recipient cells (of a concave wave) are depolarized quicker, 
which thereby increases the CV.  However, if we consider a convex wave 
(positive curvature), the situation is reversed (Figure 1.2C). Compared to the 
concave or the planar wave, the cells at the curved wave front must activate a 
relatively large number of cells ahead of them, and this results in a lower CV with 
respect to concave or planar waves. Importantly, if the convexity (positive 
curvature) of the wave front exceeds a critical value, then the cells at the wave 
front will not be able to provide enough depolarizing current to excite downstream 
cells, and conduction block occurs as a result. In the case of a spiral wave, the 
curvature of the wave front increases and the CV decreases toward the center of 
rotation. Near the very center (i.e., at the tip of the spiral), the curvature is critical 
and the velocity is zero, which forces the wavefront to pivot around an unexcited, 
but eminently excitable, core (Figure 1.2D). Thus, a spiral wave rotates around 
an area of unexcited cells that are available to be excited once they receive 
enough current to bring them above the threshold for sodium channel activation. 
As such, a spiral wave can either be stationary or rotate continuously around the 
core. It can also invade the core, or meander in complex geometrical patterns. 
Why this occurs is not entirely understood, but it is thought to be a consequence 
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of the flow of electrotonic currents between cells at the core and cells at or near 
the rotor tip. Rotor meandering or drift may also occur as a result of wave front-
wave tail interactions (see below). 
  The wave front is always followed by its wave tail, and the spatial 
extension between them is known as the wavelength (WL). The wave front 
corresponds to the AP upstroke and the wave tail corresponds to repolarization; 
therefore, in a planar wave, the WL can be approximated as CV x APD. However, 
this formula usually does not apply to a spiral wave since both APD and WL 
change with distance from the core. At the core, cells function as current sinks, 
shortening APD of the cells in its immediate vicinity, which are acting as the 
current source. Therefore, the APD and WL are smaller closer to the core and 
larger when farther away from the core (Figure 1.2D).  
  It has been shown that the frequency at which a spiral wave can rotate 
around a given core, the size of the core, and the degree of meandering of the 
wave depend primarily, but not entirely, on two factors: excitability and APD. If 
the system is highly excitable, a spiral wave can have a higher critical curvature. 
This is because of more depolarizing current in any given source cell available to 
excite downstream cells. The opposite is true for reduced excitability. In such 
situation, the curvacure of a spiral wave is lower and the propagation of wave 
front also becomes slower.   
  If the WL is large near the core, then there is a high probability that the 
wave front will collide with its tail. These wave front-wave tail interactions can 
lead to meandering of the wave, and they may eventually terminate in fibrillation 
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or lead to local wavebreaks. A shorter APD, on the other hand, will result in a 
smaller wavelength, which minimizes the chance of meandering or wavebreak to 
occur. Wavebreak happens when the wave front encounters refractory tissues, or 
when the wave front (i.e., the source) is too weak to depolarize downstream cells 
above threshold. The general consensus is that wavebreak is critical in rotor 
formation and the breakdown into turbulent activity, also termed “fibrillatory 
conduction”. 
1.1.5 Animal and Human Studies of Fibrillation 
  Based on computer simulations first using simplified excitation-diffusion 
models and later models that included specific ionic channel kinetics and millions 
of electrically coupled cells, investigators predicted that any shortening of the 
APD or increase in the excitability should stabilize spiral waves [70, 71]. Further, 
it was predicted that gradients in APD/excitability should provide a substrate for 
wavebreaks. Since wavebreaks serve as a “footprint” for the formation of scroll 
waves, it was thus postulated that should wavebreaks occur in the heart, 
fibrillation dynamics should consequently change, based on the above 
predictions.  
  In experiments with isolated Langendorff-perfused guinea pig hearts, 
Warren et al. visualized a long-lasting stable rotor in the LV as well as the 
breakup of 1:1 propagation in the right ventricle [72], which resulted in a left-to-
right gradient in VF frequency. Combining this observation with subsequent 
advances in molecular biology, the molecular mechanisms responsible for 
fibrillation gained a solid foundation as it was beginning to be explored. It was 
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then soon discovered that a spatial gradient of IK1 density existed between the 
left and right ventricles in guinea pig heart presumably a result of the left ventricle 
having a higher expression level of Kir2.1, which is the primary protein 
component of IK1 in the ventricles [58]. Further, perfusion with BaCl2 at low 
concentrations that preferentially block IK1, slowed and then terminated VF in all 
cases studied. The finding that a gradient of the inward rectifier current is 
responsible for frequency gradients is not limited to just the ventricle, as similar 
results, and gradients, have been found in the atria as well [73]. For example, the 
left atrium has a higher density of IKACh (an inward-rectifing potassium current 
activated by releasing of acetylcholine (ACh)), and it also has a higher dominant 
frequency than the right atrium during AF [74]. 
  In 2004, Li et al. generated a transgenic mouse model in which   Kir2.1 
was overexpressed specifically in the heart [75]. This Kir2.1 overexpressing 
mouse had a slightly more negative resting membrane potential and a drastically 
shorter APD than the littermate wild type (WT) mice. In optical mapping 
experiments, Noujaim et al. demonstrated that VF in the Kir2.1 overexpressing 
mouse heart was much more stable and faster (~ 43.5 Hz; 5.8 minutes) than that 
observed with WT hearts (~26.3Hz; 3 seconds), as predicted by simulations [76]. 
Such data suggested a major role for IK1 in the control of the frequency and 
stability of rotor activity during VF in the mammalian heart. 
  In 2008, Muñoz et al. investigated the role of the slow component of 
delayed rectifier, IKs, in fibrillation dynamics [77]. Using a neonatal rat ventricular 
myocyte (NRVM) monolayer model, they demonstrated that, in contrast to IK1 up-
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regulation, IKs overexpression resulted in post-repolarization refractoriness. As a 
result of the effective refractory period outlasting the APD, Muñoz et al found that 
there was an increase in the formation of wavebreaks and fibrillatory conduction 
without significant change in rotor frequency, likely due to IKs’s accumulation 
effect at high frequency.  
  Experiments using animals (sheep [78] and rabbit [79]) have 
demonstrated that sodium channel blockade reduces excitability, which therefore 
leads to slow propagation and reduces the stability and frequency of rotors. As a 
result, meandering, and ultimately, termination of VF occurs by collision of the 
rotor with a boundary. However, it is known that sodium channel blockade can be 
proarrhythmic, as demonstrated in the Cardiac Arrhythmia Suppression Trial 
(CAST) [80]. Further, one of the most common conditions that predispose an 
individual to VF is heart failure, which itself results in a prolongation of the APD 
[81]. Taking experimental and clinical data together, there seem to be some 
discrepancies between the theory of rotors and what actually happens in the 
human heart. Are such discrepancies the result of flaws in the theory or do they 
rather represent inherent limitations of our experimental approach to study VF in 
a mammalian system? In order to address these important questions, it is 
necessary to better understand the molecular mechanisms of reentry arrhythmias 
at the cellular as well as at the whole organ levels.  
1.1.6 Monolayers as a Model to Study Spiral Waves 
  Cultured NRVM monolayers are electrically coupled and can contract 
synchronously. Recently, monolayers have been generated from human stem 
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cell derived myocytes in order to study human electrophysiology [82]. While 
artificial compared to the 3D heart, both human and neonatal rat cardiomyocyte 
monolayers provide an ideal model in which to study spiral wave dynamics under 
a variety of different conditions (e.g. overexpression/silencing of various proteins, 
heterocellular coupling of non-myocytes to cardiomyocytes). Either rat or human 
monolayer can be used as an ideal model for the study of spiral waves. They can 
be easily visualized, and the cells that constitute the monolayer are biological in 
origin. Further, they contain biological and electrophysiological parameters that 
cannot be taken into account with the current computer modeling  due to the 
inherent limitations in processing power, etc. [83]. Despite being a reductionist 
technique, our laboratory has successfully used the NRVM, and now human iPS-
derived cardiomyocyte monolayer model to study how different ion channels and, 
more importantly, how other cell types influence spiral wave activity. 
  One area in which our laboratory as well as other groups have used the 
monolayer system is to examine how different repolarizing potassium currents 
affect spiral wave biophysics. Specifically, we demonstrated that spiral wave 
stability and break up can be modulated by the amount of IKs [77]. Leslie Tung’s 
laboratory has shown that heterogeneity of IK1 in NRVM can influence spiral 
wave dynamics as well [84]. However, the effects of another important 
repolarizing current, IKr, in controlling rotor dynamics remained unstudied until 
this dissertation (Chapter 2).  
  Recently, more complex monolayer models have been generated and 
characterized. Different cell types have been introduced into a given monolayer 
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of cardiomyocytes, including cardiac fibroblasts [85], genetically modified HEK 
cells [86], and human stem cells [87]. These new models have helped to further 
expand our understanding of how the interaction between cardiomyocytes and 
different cell types impacts electrical impulse propagation. For example, our lab 
has developed a heterocellular monolayer model composed of randomly 
distributed NRVM and neonatal rat ventricular fibroblasts (NRVF) in order to 
mimic the pathological situation of fibroblast infiltration [85]. The data obtained 
from studies using this model have provided solid evidences to support that 
strong correlations exist between the proportion of fibroblasts and CV, rotor 
frequency, and fibrillatory conduction. A higher ratio of fibroblasts to myocytes 
resulted in a biphasic change in CV, a reduction in rotor frequency and increase 
in fibrillatory conduction. Therefore, I took advantage of this heterocellular model, 
and investigated whether genetically modified cardiac fibroblasts could have the 
opposite effect when coupled with native cardiomyocytes (Chapter 3).  
 
1.2 Functional Determinant of Rotor Dynamics 
  While rotors have been recognized as the main mechanism underlying VF 
for years, the ionic mechanisms responsible for their behavior are still 
incompletely understood. Previous studies suggested that the frequency and the 
stability of rotors are determined in great measure by the RMP and CV. These, in 
turn, are largely controlled by the dynamic interplay between the outward 
component of the inward rectifier potassium current (IK1) and the rapid inward 
sodium current (INa). Milstein et al. demonstrated that there is a dynamic 
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reciprocity of Kir2.1 (IK1) and NaV1.5 (INa) channel expression that exits across 
different species [88]. These results further suggested that the relationship 
between IK1 and INa plays a central role in controlling membrane properties in the 
heart.  
  Our laboratory has shown that upregulation of the slow delayed rectifier 
potassium channels (IKs) does not affect reentry frequency, but does significantly 
increase the incidence of fibrillatory conduction [77]. However, when I started my 
doctoral work, it was not known how the rapid delayed rectifier current (IKr) 
influences spiral wave dynamics. In Chapter 2, I will present the 
electrophysiological consequences of increasing IKr in rotor frequency and spiral 
wave dynamics. While the effects of IKr on spiral waves were not known prior to 
my doctoral studies, there was a large body of knowledge about the IKr current 
itself as well as data to suggest an association between variations in the 
biophysical properties of IKr and arrhythmias. 
1.2.1 hERG and LQT/SQT 
The human ether-a-go-go-related (hERG) gene (KCNH2), located on 
chromosome 7q35-q36, encodes α subunits of the channels that responsible for 
the rapid component of the delayed rectifier current IK [89]. hERG was originally 
cloned by Warmke and Ganetzky in 1994 from a human hippocampal cDNA 
library [90]. While it is clearly found in neuronal tissues, the hERG protein is most 
abundantly expressed in the heart [91].  
The rapid component of the delayed rectifier current, IKr, is important in 
determining the shape and duration of the human cardiac AP. Reduction of IKr 
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results in AP prolongation, cardiac arrhythmias, and sudden cardiac death [92]. 
In 1995, the Keating laboratory reported that mutations in hERG were associated 
with chromosome 7-linked inherited long QT syndrome (LQT2) [93].  
LQTS is defined by a QT interval prolongation on the ECG (Figure 1.1A). 
This delay in ventricular repolarization greatly increases the patient’s risk of 
developing TdP [94], which can further evolve into lethal VF. The most common 
causes of LQTS are mutations in one of three ion channel encoding genes, with 
the channel’s respective current given in parentheses: hERG (IKr), KCNQ1 (IKs) 
and SCN5A (INa) [89]. Drug-induced LQTS has also been observed in patients as 
a result of IKr blockade. For example, one side effect of the antiarrhythmic drug 
quinidine is TdP, which has been reported in ~2-9% of patients who take 
quinidine [95]. The arrhythmogenic potential of IKr blockade has resulted in 
numerous drugs being withdrawn from the market, including medications treating 
gastrointestinal disorders and allergies (e.g. cisapride and terfenadine) [96]. 
Moreover, it has also encouraged  pharmaceutical companies to more carefully 
screen their compounds for potential hERG channel blockade during the 
preclinical safety assessment [97]. 
However, the arrhythmogenic potential associated with hERG/IKr is not 
limited only to a loss-of-function in IKr. A gain-of-function mutation of hERG, 
N588K, was identified in association with short QT syndrome (SQTS) [98]. This 
provided evidence that upregulation of IKr can also be arrhythmogenic. However, 
early studies observed an antiarrhythmic effect when hERG channels were 
expressed in adult rabbit ventricular myocytes maintained in primary culture [99]. 
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In this study by Nuss et al., cultured myocytes normally exhibited prolonged the 
APD and they were predisposed to early afterdepolarizations (EAD). An increase 
in hERG expression enhanced AP repolarization and reduced the incidence of 
EAD [99]. Therefore, upregulation of IKr was shown to exert both pro-
arrhythmogenic (SQTS) and anti-arrhythmogenic activities (in vitro rabbit 
myocyte culture). However, how alteration in IKr influences spiral wave dynamics 
was not clear from these studies. 
1.2.2 hERG Structure and Kinetics 
hERG encodes the  subunit of a classic voltage-gated potassium 
channel. The structure of the 1159 residue protein consists of  six 
transmembrane domains (S1-S6), including a voltage sensor S4 and a 
potassium selective pore region between the S5 and S6 segments (Figure 1.3) 
[92]. A functional hERG channel is composed of four subunits (tetramer). Like 
other voltage-gated potassium channels, hERG channels differ from sodium and 
calcium channels in that their four homologous domains are not covalently linked, 
but are presumably assembled by non-covalent associations. In addition to the 
transmembrane domains, the hERG  subunit also contains two cytoplasmic 
domains: the amino N- and carboxyl C-terminal domains. The hERG N-terminus 
contains a PAS (Per-Arnt-Sim) domain, which is believed to play a role in the 
deactivation process of the channel [100]. The C-terminus contains a cyclic-
nucleotide-binding domain (cNBD), which has been shown to affect channel 
trafficking and processing in the endoplasmic reticulum [101]. hERG  subunit 
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also interacts with KCNE2, accessory subunits which modulate the channel’s 
biophysical properties [102].  
 In 1995, Sanguinetti et al. and Trudeau et al. reported the gating 
properties of hERG channels in Xenopus oocytes [93, 103]. hERG channels 
have three states: closed, open, and inactivated. The gating kinetics of hERG 
channels is very unusual. The channel exhibits rectification similar to that of the 
inward rectifier potassium channel. The mechanism of this inward rectification 
process was shown to be the result of a fast and voltage dependent inactivation 
that reduces whole cell channel conductance at positive voltages, by Smith et al. 
in 1996 [104].  
Voltage-gated potassium channels have different mechanisms of 
inactivation [105]. The first one is N-type inactivation, which is commonly referred 
to as ball-and-chain inactivation since it is believed that amino acids swing into 
the pore in order to prevent ion fluxes. Another type is C-type inactivation, which 
is believed to involve changes in the 3D conformation of the channel as a means 
of preventing ion fluxes. Regardless of the mechanism of inactivation, the ion 
channel again becomes capable of allowing ion flow when the transmembrane 
voltage returns to more hyperpolarized potentials.  
In 1996, three groups using different approaches independently ruled out 
the possibility of N-type inactivation with respect to hERG channels [104, 106, 
107]. Each of them provided evidences that the inactivation is neither sensitive to 
internal TEA (tetraethylammonium) application nor to the deletion of the N-
terminus. Thereafter, investigators recognized the inactivation of hERG channels 
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as being analogous to the “C-type” mechanism of inactivation [108, 109]. In 
accordance, and similar to that observed for Shaker (the first cloned potassium 
channel [110]), hERG inactivation is sensitive to the ion occupancy of a 
selectivity filter as well as to external TEA application [104, 106]. Moreover, when 
Ser631 is mutated in hERG, the inactivation process is compromised. Ser631 is 
functionally equivalent to Thr449 in Shaker in that each residue is critical to the 
C-type inactivation of its respective channel [111, 112]. However, inactivation of 
hERG channels is fast and voltage-dependent, while it is the opposite (slow and 
voltage insensitive) for Shaker channels [109]. Compared to the rapid inactivation 
of hERG, the activation process of hERG channels is unusually slow.  
Wang et al. was the first to study the voltage dependence of hERG 
activation in detail [113]. They proposed a three closed state activation model 
with a voltage-insensitive intermediate closed state, which accurately reproduced 
the time and voltage dependence of the activation and deactivation of hERG. In 
addition, they pointed out that the activation process was insensitive to 
extracellular potassium, but inactivation was sensitive to changes in potassium 
concentration. When [K]o was changed from 2 to 98 mM, Wang et al. reported 
that hERG inactivation did indeed undergo a shift of ~30 mV towards 
depolarization. 
 Recent studies have discovered an alternatively processed hERG isoform, 
hERG1b, which has identical transmembrane and cytoplasmic domains as 
hERG1a but contains a truncated N-terminus [114, 115]. hERG1b is 340 amino 
acids shorter than hERG1a, and is able to form heterotetrameric channels with 
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hERG1a. Compared to hERG1a alone (homotetrameric channel), the 
heterotetrameric channel has a faster activation, deactivation, and recovery from 
inactivation [116]. This partially explains the differences in gating kinetics 
between native IKr in myocytes and the current through hERG channels 
composed of hERG1a alone in autologous cells [117, 118]. 
1.2.3 hERG Contribution to Repolarization 
  The contribution of IKr to repolarization has been recognized for decades. 
hERG channels are active during phases 2 and 3 of the cardiac action potential. 
The balance between hERG current and L-type calcium current contributes to the 
plateau phase of the action potential. The prolonged plateau phase ensures that 
adequate extracellular Ca2+ enters the cell to enable excitation-contraction 
coupling. It also allows the cardiac tissue a period to remain refractory, and 
hence, it serves to partially protect the heart from the propagation of premature 
beats/arrhythmia [92]. hERG channels start to open when the membrane 
potential is depolarized above -60 mV. While depolarization continues, hERG 
channels rapidly enter into an inactivation state, which reduces the membrane 
conductance and the outward current. It results in low hERG current flow during 
depolarization and the plateau phase. However, during repolarization, hERG 
channels recover from inactivation at a faster rate than deactivation, and this 
initiates phase 3 repolarization of the AP. This progressive increase in hERG 
current causes the repolarization of the cardiomyocyte to continue, and it 
eventually reaches the maximal current before the final rapid declining phase of 




1.3 Structural Determinants of Impulse Propagation 
  While ion channels are paramount to cardiac impulse propagation and 
myocytes contraction, the heart also contains numerous cell types and structures 
that are not actively involved in contraction. Nevertheless, they are crucial to 
normal heart physiology and as new evidence suggests, also to arrhythmias. 
1.3.1 Fibrosis and Arrhythmia 
  Cardiac pathologies generally lead to structural remodeling and the 
development of fibrosis [119]. These processes are often accompanied by 
cardiomyocyte hypertrophy, fibroblast activation and proliferation, and an 
imbalanced extracellular matrix (ECM) deposit [120]. Once fibroblasts 
differentiate into myofibroblasts (MF), they are able to modify the 
electrophysiology of cardiomyocytes by heterocellular coupling via gap junctions 
[121]. On one hand, this action may rescue electrical impulse conduction 
between disconnected myocardium by acting as short-range conductors; on the 
other hand, the delayed conduction associated with unexcitable myofibroblasts 
may promote unidirectional conduction block and reentry arrhythmias.  
Although cardiomyocytes occupy 70% of the volume of the working 
myocardium, cardiac fibroblasts are the most abundant cell type in the heart 
[122, 123]. These fibroblasts are important for maintaining myocardial structure 
by forming a three-dimensional extracellular network/matrix surrounding 
myocytes in healthy myocardium. The main components of the matrix are 
collagen and elastin [124]. Under physiological conditions, the production and 
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degradation of collagen is very tightly regulated [125]. However, when an injury 
such as myocardial infarction (MI) takes place in the heart, fibroblasts 
differentiate into their active form of MF. In this state, MF proliferate and increase 
the ECM deposit. They also promote myocardial remodeling and the formation of 
a scar [126]. During this remodeling, it is common for cardiomyocytes to undergo 
hypertrophy and experience cell death [127]. As a result, where there once was 
excitable tissue (composed of healthy cardiomyocytes) is now replaced with 
unexcitable tissue infiltrated by fibroblasts/MF (fibrosis).  
Fibrosis leads to the accumulation of collagen, which may serve as an 
electrical insulating barrier for spiral wave anchoring and may thus act to stabilize 
arrhythmias [128, 129]. Also, a redistribution of connexins is often observed in 
infarcted tissue, and this could also favor the initiation and perpetuation of 
arrhythmias [129]. In addition, during reentrant arrhythmias, the rapidly 
succeeding electrical wave emanating through fibrotic myocardium generates 
fragmentation and wavelets that may lead to fibrillatory conduction. Together, 
these effects may further reduce the likelihood of arrhythmia termination. 
However, it is important to note that the arrhythmogenic potential of 
fibrosis is multi-faceted. Its effects are not merely due to the loss of healthy 
myocardium nor only to changes in myocardial connectivity in response to 
increased accumulation of ECM components. The effects of fibrosis are often 
cumulative and include both the above factors, and are often further influenced 




1.3.2 Myofibroblast and Impulse Propagation 
MF are unexcitable cells with a more depolarized resting membrane 
potential (-15 to -40 mV) and a higher membrane resistance (4 GΩ) than 
cardiomyocytes [130-132]. Therefore, when MF electronically couple to 
myocytes, they can potentially serve both as current sinks for electrical charges 
as well as short and long range conductors [128, 133, 134]. MF have been 
shown to affect electrical impulse propagation by causing slow and “zigzag” 
conductions [135]. Further, by functional coupling with myocytes, MF can 
contribute to conduction block, which itself increases the probability of initiating 
reentry arrhythmias [135, 136].  
  An important feature of MF is the expression of connexins, which has 
been shown in a variety of tissues [137, 138]. Both homocellular gap junctional 
coupling with other MF and heterocellular gap junctional coupling with myocytes 
have been identified in vitro. In 1992, conductance of gap junctions in MF was 
measured and reported by Rook et al.: 21 pS between MF and 32 pS between 
MF and myocytes [130]. Using immunohistochemistry and Western blot analyses, 
subsequent studies have demonstrated expression of multiple connexin proteins 
(connexin43, connexin40 and connexin45) in MF across different species [133, 
139, 140]. It has been suggested that these connexins are able to form 
heterologous gap junctions, which may provide an explanation for the unusual 
conductance reported earlier (Cx43: ~100 pS; Cx40: ~150 pS; Cx45: ~50 pS).  
  Because of the difficulty in studying MF in complex and variable 
remodeled myocardium in vivo, a number of in-silico and in vitro models have 
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been generated to assess the functional consequences of MF-myocyte 
interactions [85, 133, 141, 142]. Using a mathematical model, MacCannelll et al. 
showed that several changes occur in the properties of myocytes when they are 
coupled to MF, including APD shortening and reduction in AP plateau height 
[142]. However, RMP of coupled myocytes was unchanged. Miragoli et al. later 
provided experimental evidences showing that MF were able to depolarize 
myocytes in a co-culture with neonatal rat myocyte strands. In this unique co-
culture model, strands of cardiomyocytes  were coated with a layer of MF at 
different plating densities [133]. As the density of MF increased, the resting 
membrane potential of the myocyte strands gradually depolarized from about -80 
mV to -55 mV. This resulted in biphasic changes in both conduction velocity and 
upstroke velocity of AP. The results from Miragoli et al. provided “proof of 
concept” evidence that MF can serve as a current sink when coupled to 
cardiomyocytes.  
  Gaudesius et al. identified a different role that MF may play in impulse 
propagation: short and long-range conductors [134]. In their in vitro model, MF at 
various lengths were inserted in the middle of two myocyte strands. Conduction 
delays were observed at shorter lengths before conduction block eventually 
occurred when MF inserts exceeded 300 µm. More recently, our laboratory 
further studied the effect of MF in initiating and maintaining reentrant arrhythmias 
[85]. To examine how MF influence spiral wave dynamics, we used a 
heterocellular model in which NRVM and MF were co-cultured at different ratios. 
Compared to control dishes (containing NRVM alone), more complex wave 
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propagation with a slower frequency was observed in dishes with high MF to 
NRVM cell ratios. Moreover, in both experiments and computer simulations, 
conduction velocity and heterocellular coupling displayed a biphasic relationship 
similar to that which has previously been shown by Miragoli et al. [133]. 
Specifically, there was an initial decrease that was followed by an increase in 
conduction velocity. This biphasic relationship can be explained by a switch in 
the role that MF plays in impulse propagation: from current sink to conductor.  As 
coupling initially increases, the MF become a stronger current sink and act to 
slow impulse propagation. This occurs until MF reaches a threshold and they are 
then able to pass enough current to initiate an AP from downstream myocytes. 
Thereafter, further increase in coupling would make MF stronger conductors, and 
this would, as a result, increase conduction velocity.  
MF can also influence the remodeling of cardiomyocytes through the 
release of multiple cytokines (e.g. TGF-β, IL-6, IL-10 and tumor necrosis factor-
α), growth factors and chemokines. These molecules have been shown to affect 
various potassium and calcium ion channels [143, 144]. Recently, our laboratory 
has demonstrated that secreted and/or exogenous cytokines and growth factors 
have significant effects on the electrophysiology and AP profile of cultured 
cardiomyocytes. In these experiments, MF conditioned medium (containing all 
the cytokines, growth factors, etc. secreted by MF in culture) or TGF-β treatment 
increased peak sodium current (INa), prolonged the APD, and promoted EADs in 
adult rat ventricular myocytes. This further supports the pro-arrhythmic effect of 
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MF in fibrotic tissues and also sheds some mechanistic insight underlying MF-
myocyte interactions.  
Altogether, several studies have suggested that MF could become a target 
to treat post MI arrhythmia [145-147]. While most of the treatments studied so far 
focus on reducing the number of MF, I proposed an alternative approach in 
Chapter 3: that transient genetic modification and expression of specific ion 
channels will make MF excitable and able to generate an AP. Our working 
hypothesis is that these newly-excitable MF will restore fast myocardium 
conduction and reduce arrhythmias in a heterocellular in vitro model of cardiac 
impulse propagation.  
 
1.4 Thesis Overview 
 Traditional pharmacological and device therapies designed to treat 
arrhythmias have indeed reduced the number of deaths from VF over the last 
decade; yet, the treatment options remain suboptimal since they introduce 
additional complications. Further, while they may initially improve the quality of 
life, they treat the symptoms rather than the causes. Arguably, the causes are 
varied, and this may complicate the search for the ideal treatment and/or 
prevention of VF. In general, the causes of cardiac arrhythmia can be divided into 
two categories: pathogenic changes in the electrophysiology of the heart 
(functional determinants) and changes in the gross anatomy of the heart 
(structural determinants). Therefore, the overall objectives of my thesis are: (1) to 
understand how changes in hERG (IKr) affect the rotor dynamics and properties 
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of VF; and (2) to determine whether genetical modification of cardiac MF will alter 
the arrhythmogenic potential and/or consequences of the remodeling associated 
with fibrosis.  
In Chapter 2, the role of hERG channel expression in impulse propagation 
is systematically studied in a NRVM monolayer model. I tested the hypothesis 
that increasing the expression level of the hERG channels will change spiral 
wave dynamics by increasing both its frequency and stability. In Chapter 3, I will 
present data to demonstrate that cardiac MF infected with adenoviral constructs 
encoding three ion channels (Kir2.1, NaV1.5, and Cx43) restore conduction 
velocity, and reduce arrhythmias in an in vitro heterocellular monolayer model.  
Finally in Chapter 4, I will discuss how the data presented in Chapters 2 
and 3 lead to an advanced understanding of the ionic mechanisms of fibrillation, 
and provide insights into the development of potential pharmacological or cell 






Figure 1.1. Electrocardiogram (ECG) and action potential. A. ECG traces 
represents a normal and Long QT (LQT) case. B. Action potential phase 0 to 4. 






Figure 1.2. Propagating wave in a 2D sheet. A. Planar wave. B. Concave 
wave. C. Convex wave. D. Rotor: electrotonic effect of the center of rotation 
(core) on conduction velocity (CV) action potential duration (APD) and 







Figure 1.3. hERG structure. Schematic diagram of one subunit of hERG 
channel with six α-helical transmembrane domains, S1-S6, and cytoplasmic N-
terminal and C-terminal domains. PAS: Per-Arnt-Sim; cNDB: cyclic-nucleotide-










A MAJOR ROLE FOR HERG IN DETERMINING FREQUENCY OF REENTRY 
IN NEONATAL RAT VENTRICULAR MYOCYTE MONOLAYERS 
 
2.1 Abstract 
The rapid delayed rectifier potassium current, IKr, which flows through the 
human ether-a-go-go-related (hERG) channel is a major determinant of the 
shape and duration of the human cardiac action potential (APD). However, it is 
unknown whether the time dependency of IKr enables it to control APD, 
conduction velocity (CV) and wavelength (WL) at the exceedingly high activation 
frequencies that are relevant to cardiac reentry and fibrillation. The objective is to 
test the hypothesis that upregulation of hERG increases functional reentry 
frequency and contributes to its stability. Using optical mapping, we investigated 
the effects of IKr upregulation on reentry frequency, APD, CV and WL in neonatal 
rat ventricular myocyte (NRVM) monolayers infected with GFP (control), hERG
1
 A significant part of this chapter was previously published in Circulation Research and  
is copyrighted by the American Heart Association (AHA) 
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(IKr), or dominant negative mutant hERG G628S. Reentry frequency was higher 
in the IKr-infected monolayers (21.12±0.8 Hz; n=43 vs 9.21±0.58 Hz, n=16; 
p<0.001), but slightly reduced in G628S-infected monolayers. APD80 in IKr-
infected monolayers was shorter (>50%) than control during pacing at 1-5 Hz. CV 
was similar in both groups at low frequency pacing. In contrast, during high 
frequency reentry, the CV measured at varying distances from the center of 
rotation was significantly faster in IKr-infected monolayers than control. 
Simulations using a modified NRVM model predicted that rotor acceleration was 
due in part to a transient hyperpolarization immediately following the AP. The 
transient hyperpolarization was confirmed experimentally. Therefore, we 
conclude that hERG overexpression dramatically accelerates reentry frequency 
in NRVM monolayers. Both APD and WL shortening, together with transient 
hyperpolarization, underlies the increased rotor frequency and stability.  
 
2.2 Introduction 
Ventricular fibrillation is a major cause of sudden cardiac death. Evidence 
suggests that, in mammalian species ranging in size from the mouse to human, 
VF may be maintained by highly periodic reentrant waves called rotors [35, 37]. 
The spiral waves that emanate from high frequency rotors propagate through the 
ventricles, and undergo intermittent, spatially distributed wavebreaks resulting in 
complex patterns of conduction also known as fibrillatory conduction [30, 35]. 
While the existence of rotors has been known for years, the ionic mechanisms 
responsible for their behavior remain incompletely understood. Recently, it was 
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shown that the frequency and the stability of rotors are determined in great 
measure by the resting membrane potential (RMP) and the conduction velocity 
(CV), which are controlled by the dynamic interplay between the outward 
component of the inward rectifier potassium current (IK1)  and the rapid inward 
sodium current (INa) [76]. Other experiments have demonstrated that 
overexpression of the slow delayed rectifier current (IKs) does not affect reentry 
frequency, but significantly increases the incidence of fibrillatory conduction in 
cardiomyocyte monolayers [77]. However, the consequences of upregulation or 
gain of function in the rapid delayed rectifier current (IKr) on reentry frequency 
and dynamics have never been directly investigated either in the heart or any 
model system.  
The human ether-a-go-go-related (hERG) potassium channel responsible 
for IKr is important in determining the shape and duration of the human cardiac 
action potential (AP) [92]. IKr suppression results in action potential duration 
(APD) prolongation, cardiac arrhythmias and sudden cardiac death [149].  hERG 
mutations are associated with chromosome 7-linked inherited long QT syndrome 
type 2 (LQTS2) [150]. In addition, drug induced LQTS is often the result of IKr 
blockade [149]. However, an arrhythmogenic phenotype is not limited to loss of 
function in IKr.   
Recently, a gain-of-function mutation in hERG, N588K, was identified to 
be associated with short QT syndrome (SQTS) [98]. It provided evidence that 
upregulation of IKr could be arrhythmogenic. Thus, it seems reasonable to 
speculate that once a reentrant arrhythmia is initiated, IKr upregulation influences 
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its dynamics. However, while IKr contributes significantly to APD, and thus 
ventricular refractoriness and wavelength (WL ≈ APD x CV) at physiological heart 
rates, it is unknown whether its time dependency enables it to control the same 
parameters at the exceedingly high activation rates of cardiac reentry and 
fibrillation. Therefore the objective of this study was to systematically determine 
how expression levels of IKr affect the frequency, stability, and duration of rotors 
in 2-dimensional NRVM monolayers.  We tested the hypothesis that through its 
direct effects of APD shortening, upregulation of hERG increases functional 
reentry frequency and contributes to its stability.   
   
2.3 Materials and Methods 
2.3.1 Isolation and Culture of NRVM Monolayers 
The isolation and culture techniques are described elsewhere [77]. Briefly, 
hearts from 1 to 2 day old neonatal Sprague-Dawley rats (Charles River, Mass) 
were removed and collected in calcium and magnesium free Hanks’ Balanced 
Salt Solution (HBSS). Then the ventricles were isolated, minced and 
enzymatically digested in a solution that contained 0.06% trypsin (Roche Applied 
Science) and 0.15% pancreatin (Sigma). After a two-hour preplating period, 
which helped avoid non-cardiomyocyte attachment, cells were cultured in M199 
medium (Cambrex) with 10% fetal bovine serum (FBS) (Cellgro), 20 U/mL 
penicillin, 20 μg/mL streptomycin, and 100 μmol/L bromodeoxyuridine (Sigma). 
Finally, myocytes were plated in 35 mm tissue culture dishes at a density of 
1x106 cells/dish for monolayers and at low density on 25 mm cover slips for 
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single cell patch-clamp experiments. To facilitate cardiomyocyte attachment, 
dishes were coated with human placental collagen type IV (Sigma). Cells were 
subsequently cultured at 37ºC, 5% CO2. 
2.3.2 Adenoviral Constructs 
We generated adenoviral constructs containing WT or G628S cDNA 
sequence of hERG tagged with GFP, using the AdEasy vector system 
(Stratagene, La Jolla, CA). Viruses were purified using a kit (Virus Purification Kit, 
Clonetech) and the titer calculated (Rapid Titer Kit, Clontech) before multicellular 
preparations were infected with varying multiplicities of infection (MOI). MOIs of 
200 and 30 were found to be optimal for uniform expression of WT and mutant 
hERG channels, respectively, based on the GFP level across the monolayer. An 
adenovirus carrying the sequence of GFP (Ad-GFP) at an MOI=10 served as 
control. All viral infections were performed after 48 hours in culture. After 
infection, the myocytes were cultured for an additional 48 hours to allow sufficient 
protein expression before mapping or patch-clamping. 
2.3.3 Electrophysiology 
In whole-cell patch-clamp experiments the bath solution was HBSS with 
Ca2+ and Mg2+ (Sigma); pH was adjusted to 7.4 with NaOH. Nifedipine (5 µM) 
and 4-AP (2 mM) were added to reduce extraneous ion currents. The pipette 
solution contained (in mM): 1 MgCl2, 5 EGTA, 150 KCl, 5 HEPES, 5 
Phosphocreatine, 4.5 K2ATP, 2mM B-hydroxybutyric acid; pH was adjusted to 
7.2 with KOH. Recordings were carried out at 37ºC using a MultiClamp 700B 
amplifier (Axon Instruments, Forest City, CA). After gigaseal formation and patch 
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break the tip potential was nulled and cell capacitive currents and series 
resistance were optimally (~80%) compensated.  IKr currents were elicited with 
0.5-second depolarizing steps applied in 10 mV increments from a holding 
potential of -60 mV to +50 mV. IKr was derived by subtracting currents recorded 
in the presence of E4031 (1 µM) from control currents. 
APs were recorded from individual myocytes using the current-clamp 
mode of the MultiClamp 700B amplifier after gigaseal formation and patch break. 
Stimulus pulses (1-2 ms duration) were generated using a World Precision 
Instruments DS8000 stimulator. The bath solution was HBSS with Ca2+ and Mg2+ 
(Sigma). The pipette solution contained (in mM): 1 MgCl2, 5 EGTA, 150 KCl, 5 
HEPES, 5 Phosphocreatine, 4.5 K2ATP, 2mM B-Hydroxybutyric acid. Recordings 
were carried out at 37 °C. 
2.3.4 Optical mapping  
High-resolution optical mapping was conducted using a CCD camera 
(80x80 pixels, SciMeasure) (Figure 2.1). Cultured dishes were placed on a 
heating chamber connected and maintained at 37°C. Monolayers were 
superfused with HBSS (in mM/L): 1.6 CaCl2, 5.4 KCl, 0.8 MgSO4, 0.4 KH2PO4, 
4.2 NaHCO3, 136.9 NaCl, 0.3 NaHPO4, 5.5 D-Glucose, and 10 HEPES; pH 7.4.  
Electrical wave propagation was recorded by staining the cells with 40 µM/L di-8-
ANEPPS (Molecular Probes) for 15 minutes. We obtained 5-seconds movies at 
200 frames/s and 2-seconds movies at 500 frames/s.  
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2.3.5 Pacing Protocol 
Monolayers were paced using 5-ms pulses at 2X threshold through a thin 
bipolar electrode. Incremental pacing started at 1 Hz, until loss of 1:1 capture or 
induction of sustained reentry. The IKr blocker, E4031 (1 µM) was superfused 
when indicated.  
2.3.6 Data Analysis 
Single Cell Electrophysiology: We used commercially available software 
(pCLAMP, version 10.2; Axon Instrument, Forster City,CA). IKr peak pulse 
currents were measured using the Clampfit subroutine of the pCLAMP software, 
normalized to cell capacitance, and plotted against voltage. 
Optical Movies: The methods for the construction of phase maps, 
activation maps and time-space plots have been described in great detail 
previously [58, 76, 77, 85, 151].  Ensemble averaging at each pixel was 
performed over 5 or more propagating wavefronts synchronized with stimuli. 
Background fluorescence was subtracted from each frame, and spatial (3x3 
pixels) and temporal (7 pixels) conical convolution filters were applied. Dominant 
frequency (DF) maps and phase maps were constructed in monolayers showing 
sustained reentry as described [152]. Optical APDs were measured at 80% 
repolarization. The local CV was measured as described.[59] Briefly, the 
distributions of activation times (50% of upstroke) for the spatial regions of 5x5 
pixels were fitted with the plane, and gradients of activation times gx and gy were 
calculated for each plane along the x and y axes, respectively. The magnitude of 
the local CV was calculated for each pixel as (gx
2 + gy
2)-1/2. Mean values and 
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standard deviations for CV and APD were calculated for the entire visible 
surfaces and for sequential activations. During pacing, wavelength (WL) was 
calculated as WL = APD x CV. However, it is well known that during functional 
reentry both APD and CV vary greatly as a function of distance from the center of 
rotation (core). Therefore, during sustained reentry, the WL was measured from 
the phase maps as the expanse between the wavefront and the end of the 
repolarization wavetail, at a fixed distance of 10 mm from the core (Figure 2.2).  
Method of measuring the wavelength (WL): As shown in Figure 2.2, WL 
during reentry was defined by the length of the black line drawn on the phase 
map 10 mm from the center of rotation (white circle) and perpendicular to the 
tangent at the wavefront (blue). In both experiments (panel A) and simulations 
(panel B) IKr upregulation reduced WL significantly during sustained reentry. 
2.3.7 Computer Simulations 
The computer simulation was performed by Dr. Makarand Deo. We have 
modified an existing mathematical model of the neonatal rat myocyte published 
by Korhonen et al [153]. This model is unique in that the cytosolic Ca2+ is a 
function of temporal as well as spatial coordinates. Due to the lack of t-tubules 
[154], calcium ions entering into the cells via membrane channels must diffuse a 
small distance through the cytosol before reaching the sarcoplasmic reticulum 
and trigger the excitation-contraction coupling  machinery. Some ionic current 
components were modified to reproduce the AP morphology and the restitution 
properties recorded from the experiments performed in our laboratory. Other 
formulations in the Korhonen model remain unchanged [153]. 
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2.3.8 Statistical Analysis 
Data are expressed as mean±SEM. Patch-clamp data were analyzed by 
two-way ANOVA with Bonferroni post-tests. Analyses of reentry frequency were 
performed using one-way ANOVA with Tukey’s multiple comparison test. A 
Student’s t test with Welch-correction was used to analyze the average APD and 
CV, as well as the maximal diastolic potential (MDP) data. p<0.05 was 
considered to be significant.   
 
2.4 Results 
2.4.1 hERG overexpression upregulates IKr in NRVM 
At 200 or 30 MOI of adenoviral expression, we observed maximal GFP-
tagged WT or G628S mutant hERG channel expression in NRVM monolayers. 
Spatially uniform protein expression was consistently confirmed by fluorescent 
microscopy as illustrated in Figure 2.3A.  
Figure 2.3B illustrates on the top the voltage-clamp protocol (see 
Methods) used to determine the voltage dependence of IKr density. The same 
panel shows superimposed representative IKr traces recorded from single NRVM 
infected with Ad-GFP (middle) or Ad-hERG (bottom). IKr current was appreciably 
increased in the Ad-hERG infected myocytes when compared to control. As 
summarized in Figure 2.3C, Ad-hERG infected cells have a significantly steeper 
current density vs voltage (IV) relation than Ad-GFP control. At 0 mV, outward 
current was 14.7 ± 1.98 pA/pF in cells expressing hERG versus 2.8 ± 0.53 pA/pF 
in cells expressing GFP (p<0.001).  As shown in panel D, the peak tail current 
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also increased significantly in Ad-hERG myocytes. However, activation of the 
normalized tail current showed no difference between the two groups in terms of 
voltage dependence (Figure 2.3E).  
2.4.2 IKr upregulation accelerates reentry frequency 
Sustained functional reentry could be obtained from monolayers infected 
by Ad-GFP, Ad-hERG and Ad-G628S. Figure 2.4A shows phase maps of single 
rotors generating spiral waves in Ad-GFP control (left), IKr-overexpressing 
(middle), and G628S-overexpressing (right) monolayers. The corresponding 
color activation maps and time space plots demonstrating the stability and 
reproducibility of the respective reentry patterns are presented in Figures 2.5 and 
2.6. Figure 2.5 presents color activation maps of sustained reentry corresponding 
to the phase maps shown in Figure 2.4. Neonatal rat ventricular monolayers 
were infected with Ad-GFP, Ad-hERG, or Ad-G628S. In Figure 2.6, we illustrate 
the original optical signals and corresponding time-space plots for the same 
experiments. Each time-space plot (bottom) was constructed along the horizontal 
white line drawn on the equivalent reentry snapshot (top). Please note that Ad-
hERG significantly abbreviated the spatial extension of the excited state (white) 
and greatly accelerated reentry frequency, as reflected by the large increase in 
the number of rotations in the respective time-space plot. In contrast Ad-G628S 
appreciably increased the spatial extension of the excited state and reduced the 
number of rotations in the time-space plot.  
The graph in Figure 2.4B compares the ranges of individual rotation 
frequencies of control monolayers with that of IKr-overexpressing and G628S-
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overexpressing monolayers. The mean values are shown as horizontal bars for 
each experimental group. The average frequency is significantly higher in IKr-
overexpressing monolayers than GFP controls (21.12±0.81, n = 43; vs. 
9.21±0.58 Hz, n = 16; p<0.001); whereas the frequency in the G628S 
monolayers is slightly lower (6.14±0.3 Hz, n=17; NS vs GFP). 
To confirm the involvement of IKr overexpression on the acceleration of 
rotor frequency, E4031, a specific IKr blocker, was superfused at a concentration 
of 1M in 23 monolayers infected with Ad-hERG. As shown in Figure 2.7, E4031 
dramatically reduced the frequency of rotation (22.75±1.24 vs. 9.82±0.74 Hz, 
p<0.05). This effect was partially reversed after a 5min washout period 
(16.72±1.03 Hz, p<0.05 vs. E4031).  
2.4.3 Wavelength shortening underlies IKr-induced rotor acceleration 
To elucidate the mechanism by which hERG accelerated reentry 
frequency, we first investigated the effect of IKr overexpression on APD and CV 
during pacing at varying cycle lengths. From high-resolution APD maps, APD80 
was measured during 1:1 activation in 11 control and 8 IKr overexpressing 
monolayers. Figure 2.8 shows examples of single pixel recordings at pacing 
cycle lengths between 1000 and 200 ms. The data demonstrates the excellent 
signal-to-noise ratio, which allowed accurate APD measurements. As shown in 
Figure 2.9A, IKr expression reduced the APD80 by more than 50% when 
compared with control during pacing at cycle length between 200 and 1000ms 
(p<0.01). On the other hand, as shown in Figure 2.9B, the mean CV of Ad-hERG 
expressing monolayers was similar to Ad-GFP monolayers at all pacing cycle 
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lengths. Moreover, the wavelength (WL = APDxCV), was significantly shorter in 
the Ad-hERG monolayers than the control group at all pacing cycle length 
(Figure 2.9C).  
We also plotted the rotation frequency in each monolayer as a function of 
the respective mean APD80 in both control and IKr overexpressing groups. As 
shown in Figure 2.10A, the relationship was very steep and highly significant for 
the Ad-hERG group. In some monolayers, hERG overexpression reduced APD80 
to less than 30 ms, which enabled rotation frequencies of 25 Hz or higher. In 
contrast in the Ad-GFP group, although the slope of the relationship was 
significant, it was much less steep and the minimal APD80 was 60ms and the 
highest rotation frequency was 12.6 Hz.  
As demonstrated previously [58, 76, 155], during functional reentry, the 
CV decreases as the curvature of the wavefront increases toward the center of 
rotation (core). We therefore measured the CV as a function of distance from the 
core to determine whether IKr affected that relationship in the same manner as IK1 
overexpression does [76]. We determined the role of wavefront curvature in 
determining the changes of reentry frequency and dynamics secondary to hERG 
modification, as illustrated in panel A of Figure 2.11: 1) A snapshot of the phase 
movie showing a rotor with a singularity point (SP) at its pivoting tip was 
randomly selected for each of a total of n=9 monolayers in each group. 2) In each 
snapshot we determined by visual inspection the orientation of the wavefront tip 
in the immediate vicinity (i.e., within 3 pixels) of the SP. 3) We then drew a line in 
that orientation across the SP. 4) Subsequently, we drew a second line 
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perpendicular (90 degree angle) to the SP crossing line and extended it to 
approximate the first ½ winding of the wavefront; i.e., to the nearest transition 
between phases blue and purple in the phase map. 5) We measured the length 
of the second line. 6) We took that length being equivalent to the diameter of a 
hemi-circle approximately delineating the wavefront in its first ½ winding and 
therefore as being inversely proportional to its curvature at that location. 
In Figure 2.10B we summarize data for 21 Ad-hERG monolayers and 12 
Ad-GFP monolayers. As expected, CV increased gradually as a function of 
distance from the core in both groups. However, the Ad-hERG monolayers 
showed a lager CV at all distances from the core as compared with the Ad-GFP 
monolayers (p<0.05). Similarly, the curvature of the wavefront near its pivot point 
was determined and compared between groups (Figure 2.11). Curvature was 
larger in the Ad-hERG monolayers than Ad-GFP controls. Taken together, this 
analysis showed that during reentry, excitability and CV are higher in the Ad-
hERG monolayers than in the Ad-GFP control.   
Figure 2.10C shows a comparison of WL measured during reentry as the 
expanse between the wavefront and the end of the repolarization wavetail (see 
Figure 2.2 and Method). As expected, the WLs were significantly shorter in the 
Ad-hERG group. They ranged between 2.75 and 6.89 mm, whereas control WLs 
ranged between 7.88 and 22.22 mm (p<0.05). Altogether the data presented thus 
far suggested that APD and WL shortening, together with increased CV underlie 
rotor acceleration in IKr-upregulated monolayers.  
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2.4.4 Numerical Simulations 
To gain further mechanistic insight into the effects of hERG 
overexpression on rotor frequency and stability, we conducted computer 
simulations at the single cell level, as well as in 2D using a modified model of the 
NRVM. Figure 2.12A shows APs elicited in the single cell model by pacing at 1 
Hz in control, and hERG increase (IKr 5.21X). As expected, APD abbreviated 
upon IKr upregulation. Interestingly, in the IKr 5.21X model the AP was followed by 
a highly reproducible transient hyperpolarization (see also Figure 2.13A).   
We investigated the consequences of IKr upregulation on rotor dynamics in 
a 2D monolayer model. As shown in Figure 2.12B, the reentry frequency was 
significantly increased from 12.8 Hz in control to 18.5 Hz in IKr 5.21X, which was 
consistent with the experimental result shown in Figure 2.4. Similar to 
experiments, overexpressing IKr (5.21X) in the simulations increased the CV 
during reentry at all distances from the core compared with the controls (Figure 
2.12C). 
To determine whether the changes seen in Figure 2.12A had any role in 
IKr overexpression-induced rotor acceleration, we subjected the single cell model 
to pacing at varying frequencies (from 1 to 20 Hz). We surmised that at the 
highest frequencies the ensuing APD shortening and transient hyperpolarization 
should increase INa availability and therefore excitability. To test that hypothesis, 
the fast inward sodium current (INa) was recorded in two sets of simulations 
(control, and IKr 5.21X, respectively), and peak INa was plotted against pacing 
frequency for each case. As a negative control, in yet another set of simulations 
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we scaled IKs (25X) while IKr was kept unchanged. Differences in cell excitability 
were investigated in both sets in terms of peak INa amplitude. As shown in Figure 
2.13A, while IKr upregulation produced a concomitant transient hyperpolarization 
after the abbreviated action potential (left), IKs upregulation  did not result in 
membrane hyperpolarization (top right). Therefore, as shown in Figure 2.14B, the 
effects of IKs upregulation on INa availability were substantially less at any given 
activation frequency, compared with the effects of IKr upregulation. The difference 
was most significant at the highest frequencies between 12 and 20 Hz. This 
could explain the effect of IKr upregulation on CV increase during high frequency 
reentry (Figure 2.10B) but not low frequency pacing (Figure 2.9B).  
As discussed above in Figure 2.10A, the slope of the line defining the 
relationship between rotation frequency and APD was steeper in the case of 
hERG overexpression than in control. We surmised that such an increase in the 
sensitivity of rotation frequency to APD abbreviation was the result of the 
transient hyperpolarization. Therefore, we studied the effects of premature stimuli 
(S1-S2 protocol) in single cell, 1D cable and 2D monolayer models (Figure 2.14). 
In Panel C of Figure 2.13, a single IKr 5.21X cell was paced at 2 Hz (S1) for 10 
seconds followed by a premature stimulus (S2) at varying intervals. It is clear 
from that graph that at the shorter S2 intervals, more INa was activated in IKr 
5.21X model compared to control. This increase in peak INa disappeared when 
the transient membrane hyperpolarization was suppressed by clamping the 
maximal diastolic potential (MDP) to -70 mV. As illustrated in panel A of Figure 
2.14, in the 1D cable of 10 mm in length, this increase in INa translated into 
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increased CV which again disappeared when the MDP was clamped to -70 mV. 
We further verified the role of the transient hyperpolarization during reentry in 2D 
monolayer models by clamping the MDP to various voltages. As expected, the 
frequency of reentry was progressively reduced with increasing the value of MDP 
(see panel B of Figure 2.14. The clamped voltages in these simulations covered 
the range of our experimentally observed MDPs and thus clearly underscored the 
role of the transient hyperpolarization in addition to the APD abbreviation in 
increasing the rotor frequency and CV during reentry in IKr upregulation.     
2.4.5 IKr-Induced transient hyperpolarization in NRVM  
To determine whether a transient hyperpolarization predicted by 
simulations occurred experimentally in the in NRVM, we obtained single cell 
action potential recordings using current clamp. In Figure 2.15A, we present 2 
representative action potential recordings at a pacing cycle length of 2000 ms. 
Consistent with the simulation results, APD shortening and a transient 
hyperpolarization were demonstrated in the myocytes infected with Ad-hERG 
when compared to Ad-GFP. In Figure 2.15B, we quantified the MDP after each 
action potential in Ad-hERG (-67.6±0.98 mV; n= 8) and Ad-GFP cells (-63.9±1.11 
mV; n=6; p=0.03). As shown in Figure 2.15C, APD was measured at three 
different levels (APD30, APD50 and APD80) and showed a significant reduction 
when hERG was overexpressed. Taken together, these results demonstrated 
that APD shortening and transient hyperpolarization are both important 





We have investigated the consequences of IKr upregulation on electrical 
impulse propagation and reentry dynamics in 2-D biological and numerical 
models. The most important results in this chapter are as follows: 1. IKr 
overexpression significantly increased the frequency of reentry. 2. During pacing 
at 1-5Hz, IKr overexpression shortened APD and WL more than 50%, but did not 
affect the CV. 3. During sustained reentry, rotation frequency demonstrated a 
steep and highly significant dependence on IKr upregulation-induced shortening 
of APD. The CV was significantly larger in the hERG group vs. the control group 
at all distances from the core. In addition, the WL was significantly shorter in Ad-
hERG monolayers than in control. 4. Computer simulations and single cell action 
potential recordings demonstrated that APD shortening and the transient 
hyperpolarization after each AP in hERG overexpressing NRVM increased the 
INa availability, which contribute to the increased rotor frequency. 
 
2.6 Clinical Relevance 
Advances in pharmacological treatment of VF require a detailed study of 
the molecular and ionic mechanisms underlying cardiac excitation and its 
frequency dependence. There is currently a debate on whether block of IKr is 
arrhythmogenic, or is only arrhythmogenic in a subset of patients with a genetic 
predisposition [156]. Further increases in IKr have shown to be associated with 
short QT syndrome (SQTS). Patients with this syndrome have been shown to 
have a high incidence of syncope, sudden cardiac death (SCD), and 
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supraventricular arrhythmias [157]. Our experiments show that increased hERG 
can lead to fast and stable reentry, which could be the mechanism underlying 
arrhythmias in SQTS patients. Therefore, specific hERG blocker might be 
beneficial to some patients with an upregulation in hERG or with SQTS. 
 
2.7 Study Limitations 
The effect of hERG was examined in the NRVM monolayer model, which 
allowed us to overexpress hERG channel and study its effect on reentry 
dynamics in a highly controlled environment. However, by overexpressing the 
hERG channel alone we have not considered the importance that the regulatory 
-subunits have in reconstituting native IKr, or their role in controlling reentry 
frequency [158]. Further, the consequences of channel expression in neonatal 
rodent myocytes are likely to be different from those in human adult myocytes 
since the ionic profile is different. Also, the closeness of the RMP to the K+ 
equilibrium potential in normally polarized adult cardiomyocytes would 
substantially diminish the contribution of the transient hyperpolarization to the 
overall effect observed in NRVM. However, reentry typically occurs in association 
with ischemia/reperfusion injury — a situation in which external K+ is usually 
elevated — therefore, depolarization of the RMP may increase the relevance of 
the latter mechanism in the adult heart. Finally, the conclusions that have been 
drawn from this study are only conceptual and mechanistic in relation to the 
cardiac fibrillatory process. In no way do we attempt to relate them to the clinical 
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setting. Further studies in translational models would be necessary before any 
extrapolation to humans can be made.   
 
2.8 Conclusion 
This is the first study to systematically evaluate the role of IKr in the 
frequency and stability of reentry. We demonstrate that hERG overexpression 
dramatically accelerates reentry frequency in NRVM monolayers. APD 
shortening and transient hyperpolarization induced increase in excitability are the 
mechanisms underlying reentry acceleration.  
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Figure 2.1 Schematic representation of the optical mapping setup. NRVM: 







Figure 2.2. Wavelength measurement in experiments and simulations. A. 
Snapshots of the phase movies in Ad-GFP and Ad-hERG infected monolayers. 
White circles indicated the distance of 10 mm from the center of the reentry. In 
each panel, WL is given by the length of the black line extending between the 
wavefront (blue) and the end of repolarization wavetail (yellow). Scale bar: 10 






Figure 2.3. Adenoviral expression of hERG protein in neonatal rat 
ventricular cardiomyocytes after 48 hours of infection. A. GFP-tagged WT 
hERG channel expression. Left: fluorescent micrograph of a 4-day-old neonatal 
rat ventricular myocyte monolayer 48 h after viral infection. Right: corresponding 
phase contrast micrograph. Scale bar = 100 µm. B. Voltage clamp protocol (top) 
and representative examples of currents from Ad-GFP (middle) and Ad-hERG 
(bottom) infected myocytes. C. I-V relationship of the E4031-sensitive current 
normalized to cell capacitance in neonatal rat ventricular myocytes infected with 
Ad-GFP (open circles; n=5) and Ad-hERG (filled circles; n=5). ***p < 0.001, **p < 
0.01, *p < 0.05; Ad-hERG vs. Ad-GFP, two-way ANOVA with Bonferroni post-
tests. D. I-V relationship of the peak tail currents. E. Normalized peak tail 






Figure 2.4. Effects of hERG infection on reentry frequency in NRVM 
monolayers. A. Snapshots from representative optical mapping movies in 
monolayers infected with Ad-GFP (left), Ad-hERG (middle), or Ad-G628S (right). 
B. Reentry frequencies in individual monolayers infected with Ad-GFP (open 
circles), Ad-hERG (closed circles; p<0.05 vs. GFP), or Ad-G628S (open 
triangles; NS vs. Ad-GFP; p<0.05 vs. Ad-hERG). Horizontal bars represent mean 






Figure 2.5. Activation maps of the NRVM monolayers infected with Ad-GFP, 
Ad-hERG, or Ad-G628S. Scale bar on the right of each map indicates different 






Figure 2.6. Optical signals and time-space plot (TSP) show the singularity 
points in monolayers infected with Ad-GFP, Ad-hERG, or Ad-G628S. TSPs 
were constructed for activity recorded along the horizontal white lines in the 






Figure 2.7. Effect of E4031 on reentry frequency in IKr monolayers. Reentry 
frequencies of hERG overexpressing monolayers before (black) and after (grey) 
superfusion of E4031; and reentry frequency after 5 min washout (white). One-






Figure 2.8. Single pixel recordings from Ad-GFP and Ad-hERG infected 
monolayers under pacing cycle length of 1000ms, 500ms, 333ms, 250ms, 






Figure 2.9. Effects of hERG overexpression on action potential duration 
(APD), conduction velocity (CV) and wavelength in monolayers paced at 
varying frequencies. A. Frequency dependence of APD80. Mean values are 
statistically different (p<0.05). B. Frequency dependence of CV. Control values 
are not significantly different (NS) from Ad-hERG values at any pacing frequency; 
C. Frequency dependence of wavelength (WL=CV x APD). Mean values are 





Figure 2.10. Effects of hERG overexpression on mean APD, CV and WL 
during sustained reentry in Ad-GFP (open symbols) and Ad-hERG 
monolayers (closed symbols). A. Rotation frequency as a function of APD80. 
The regression lines relating frequency to APD is significantly steeper in Ad-
hERG monolayers than control (p<0.05). Solid lines indicate linear regressions. B. 
CV as a function of distance from the center of rotation (core). CV is significantly 
higher in Ad-hERG than Ad-GFP infected monolayers at all distance from the 
core during reentry (p<0.05). C. Wavelength of reentry. The difference is 




Figure 2.11. Rotor curvature in monolayers infected with Ad-GFP and Ad-
hERG. A. Snapshots of the phase movies in Ad-GFP and Ad-hERG infected 
monolayers. White lines indicated the distance between the tip of rotating spiral 
wave (Singularity point at center of core) to the wavefront at ½ of the spiral wave 
full winding (the boundary between blue and purple bands – see text). Scale bar: 
10 mm; B. quantification of the distance between the core and the wavefront. *: 
p<0.05. Long white lines: The orientation of the wavefront at the tip. Short white 
lines: Orientaion perpendicular to the wavefront at the tip; used to measure the 





Figure 2.12. Numerical simulation using a neonatal rat ventricular myocyte 
(NRVM) model. A. Simulated action potentials in control and IKr 5.21X. Note 
progressive APD abbreviation and transient hyperpolarization after the action 
potential in IKr 5.21X. B. Top, snapshots of 2D simulations of reentry in control 
and IKr 5.21X in a NRVM model. Reentry frequency is 12.8 Hz in control (left) and 
18.5 Hz in IKr 5.21X (right). Bottom, action potentials calculated at the position of 
the white dot on each reentry snapshot. Scale bars, horizontal = 50 ms; vertical = 





Figure 2.13. Simulations demonstrate different consequences of IKr vs IKs 
upregulation on membrane potential and INa availability. A. Superimposed 
single cell action potentials obtained in control (gray traces), IKr 5.21X (black 
traces, left) and IKs 25X (black traces, right). The APD shortening effect of 
increasing IKr was greater than IKs. In addition, transient hyperpolarization 
occurred only for IKr upregulation. Inset, expanded voltage versus time trace 
emphasizes IKr-induced transient hyperpolarization. B. INa peak density as a 
function of pacing frequency in control, IKr 5.21X and IKs 25X increase. For control 
and increased IKs, the magnitude of INa decreased monotonically with increasing 
pacing frequency. For IKr upregulation, INa increased at pacing frequencies 
between 10 and 20 Hz indicating increased cell excitability. C. A single cell IKr 
5.21X model was paced at 2 Hz for 10 sec (S1) followed by a premature S2 
stimulus. At shorter S2 intervals, significantly higher INa was observed as 
compared to control. This increased INa availability was suppressed when the 





Figure 2.14. Effects of transient hyperpolarization in the IKr 5.21X model. A. 
The same S1-S2 protocol as in Fig. 7C was used in a 1D cable of 10 mm length. 
The increase in INa was translated into proportional increase in CV for all S2 
intervals. Note that the increase in CV was not observed when the MDP was 
clamped to -70 mV. B. The frequency of reentry in 2D IKr 5.21X monolayer model 
decreased progressively when the MDP was clamped to more positive voltages, 








Figure 2.15. IKr overexpression produces transient hyperpolarization after 
each action potential in isolated NRVM. A. Representative current clamp 
recordings. Left: action potential in myocyte infected with Ad-GFP; Right: action 
potential in myocyte infected with Ad-hERG. B. Maximal diastolic potential in Ad-
hERG and Ad-GFP cells. C. Frequency dependence of APD30 (squares), APD50 
(triangles) and APD80 (circles) in myocytes infected with Ad-GFP (filled symbols) 









GENETICALLY ENGINEERED EXCITABLE CARDIAC FIBROBLASTS 
COUPLED TO CARDIOMYOCYTES RESCUE NORMAL PROPAGATION AND 
PREVENT ARRHYTHMIAS IN HETEROCELLULAR MONOLAYERS 
 
3.1 Abstract 
The use of genetic engineering of unexcitable cells to enable expression 
of gap junctions and inward rectifier potassium channels has suggested that cell 
therapies aimed at establishing electrical coupling of unexcitable donor cells to 
host cardiomyocytes may be arrhythmogenic. Whether similar considerations 
apply when the donor cells are electrically excitable has not been investigated. 
Here we tested the hypothesis that adenoviral transfer of genes coding Kir2.1 
(IK1), Nav1.5 (INa) and connexin-43 (Cx43) proteins into neonatal rat ventricular 
fibroblasts (NRVF) will convert them into excitable cells, rescue rapid conduction 
velocity (CV) and reduce the incidence of complex reentrant arrhythmias in an in 
vitro model. We used adenoviral (Ad-) constructs encoding Kir2.1, Nav1.5 and 
Cx43 in NRVF. In single NRVF, Ad-Kir2.1 or Ad-Nav1.5 infection enabled us to 
regulate the densities of IK1 and INa, respectively. At varying MOI ratios of 10/10, 
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5/10 and 5/20, NRVF co-infected with Ad-Kir2.1 + Nav1.5 were hyperpolarized 
and generated action potentials (APs) with upstroke velocities >100 V/s. 
However, when forming monolayers only the addition of Ad-Cx43 made the 
excitable NRVF capable of conducting electrical impulses (CV=20.71±0.79 cm/s). 
When genetically engineered excitable NRVF overexpressing Kir2.1, NaV1.5 and 
Cx43 were used to replace normal NRVF in heterocellular monolayers that 
included NRVM, CV was significantly increased (27.59±0.76 vs. 21.18±0.65 cm/s, 
p<0.05), reaching values similar to those of pure myocytes monolayers 
(27.27±0.72 cm/s, NS). Moreover, during reentry, propagation was faster and 
more organized, with a significantly lower number of wavebreaks in heterocellular 
monolayers formed by excitable compared with unexcitable NRVF. We 
concluded that viral transfer of genes coding Kir2.1, Nav1.5 and Cx43 to cardiac 
fibroblasts endows them with the ability to generate and propagate APs. The 
results provide proof of concept that cell therapies with excitable donor cells 
increase safety and reduce arrhythmogenic potential. 
   
3.2 Introduction 
Cell therapy, which involves the introduction of new cells into host tissue, 
is emerging as a novel therapeutic approach in heart disease [159]. Numerous 
studies have shown that by using bioengineered tissue, including stem and 
somatic cells, there can be successful modification of the electrophysiological 
properties of host cardiomyocytes [160-162]. Further, antiarrhythmic effects of 
cell therapy have been observed both in vitro and in vivo [163]. However, recent 
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studies suggested that coupling of unexcitable cells, which are commonly used in 
cell therapy, to cardiomyocytes might yield different functional outcomes that can 
be arrhythmogenic [164]. Recently, Yankelson et al. showed that when 
fibroblasts transfected to express the voltage-sensitive potassium channel KV1.3 
were co-cultured with NRVM they reduced significantly (to 68%) the spontaneous 
beating frequency of the cultures [163]. Subsequently, McSpadden et al. 
demonstrated that coupling cardiomyocytes with human embryonic kidney 
(HEK293) cells overexpressing connexin-43 (Cx43) modulates pacemaker 
activity and slows impulse conduction by as much as 5 times [164]. Miragoli et al. 
found similar slowing in conduction velocity (CV) in cardiomyocytes monolayers 
covered with fibroblasts expressing Cx43. Accompanying the reduction of 
conduction was a significant depolarization in host cardiomyocytes’ resting 
potential (RMP) from -78 mV to -50 mV [133]. Our previous studies using co-
cultures of randomly distributed NRVM and neonatal rat ventricular fibroblasts 
(NRVF), which express low levels of Cx43 and repolarizing potassium currents, 
demonstrated correlations between the proportion of fibroblasts and the amount 
of conduction and rotor frequency slowing, the number of wavebreaks, and the 
degree of fibrillatory conduction [85]. The above studies brought attention to the 
potential arrhythmogenic consequences of using unexcitable cells in an attempt 
to regenerate normal cardiac function in compromised myocardium. To our 
knowledge, no one has studied the electrophysiological consequences when the 
donor cells are engineered to be fully excitable and capable of generating action 
potentials (APs).   
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A crucial condition for any approach used in cell therapy in cardiology is 
the absence of pro-arrhythmia. This can be achieved when the safety of electrical 
wave propagation between the donor cells and the host myocardium is preserved 
by both a high level of excitability and an appropriate degree of intercellular 
communication at the interface. Therefore, it seems reasonable to assume that, 
using excitable donor cells capable of generating APs as cell therapy would 
rescue rapid CV and reduce the incidence of complex reentry arrhythmias. To 
prove this concept we conducted experiments in a heterocellular in-vitro model of 
cardiac impulse propagation. Since NRVF are unexcitable cells lacking sufficient 
densities of the two essential currents for the generation of ventricular myocyte-
like APs (i.e., the inward rectifier current, IK1 and the rapid inward sodium current, 
INa [132, 165]), we tested the following two hypotheses: 1. adenoviral transfer of 
genes coding Kir2.1 (IK1) and Nav1.5 (INa) proteins converts NRVF into excitable 
cells; 2. adenoviral transfer of genes coding Kir2.1, Nav1.5 and Cx43 proteins 
into NRVF enables them to couple with host cardiomyocytes, rescue rapid CV 
and reduce the incidence of complex reentry arrhythmias in an in vitro model.  
 
3.3 Materials and Methods 
3.3.1 Isolation and Culture of NRVF and NRVM 
This study followed guidelines for animal research of the University of 
Michigan. The protocol was approved by the University Committee on Use and 
Care of Animals (Approval Number: 09996-2). All surgery was performed after 
anesthesia by inhalational administration of isofluorane to minimize suffering. 
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Neonatal rats were euthanized by decapitation. Ventricular myofibroblasts and 
myocytes were isolated and cultured as described by Zlochiver et al. [85]. Briefly, 
hearts were removed from 1 to 2 day old Sprague-Dawley rats (Charles River 
Laboratories, MA) and collected in calcium and magnesium free Hanks’ 
Balanced Salt Solution (HBSS). Ventricles were then isolated, well minced and 
digested in a solution that contained 0.06% trypsin (Roche Applied Science, IN) 
and 0.15% pancreatin (Sigma, MO). A two-hour pre-plating period was used to 
separate early attached NRVF and unattached myocytes. NRVF were cultured in 
M199 medium (Cambrex, NJ) with 10% fetal bovine serum (FBS) (Cellgro,VA), 
20 U/mL penicillin, 20 μg/mL streptomycin; while myocytes were cultured in the 
same medium with additional 100 μmol/L bromodeoxyuridine (Sigma, MO). Cells 
were subsequently cultured at 37ºC, 5% CO2. At passage 3 NRVF were plated 
sparsely for patch clamp experiments, and at high density to form either pure 
NRVF monolayers (500,000 NRVF/35 mm dish) or heterocellular monolayers 
(800,000 NRVM or 80%/35 mm dish; 200,000 NRVF or 20% /35 mm dish) for 
optical mapping experiments. All NRVF used in this study were passage 3 
cardiac myofibroblasts, as demonstrated by α-SMA immunostainning.  
3.3.2 Adenoviral Constructs 
We generated adenoviral constructs containing the human Cx43 cDNA 
sequence (Ad-Cx43) using the AdMax adenoviral vector creation system 
(Microbix Biosystems, Mississauga, Ontario, Canada).  Human Cx43 cDNA was 
inserted into the pDC315 shuttle vector. The constructed shuttle vector and 
adeno-genomic plasmid pBHGloxΔE1,3Cre were co-transfected into Microbix 
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293 cells using the Ca2+-phosphate transfection method. Viruses were then 
purified using ViraBind adenovirus purification kit (Cell Biolabs, San Diego, CA) 
and the titer was calculated by a plaque forming assay before multicellular 
preparations were infected with varying multiplicity of infection (MOI). Based on 
immunostaining 10 MOI was found to be optimal for uniform expression of Cx43 
proteins. The adenovirus expressing mouse Kir2.1 (Ad-Kir2.1) was generously 
provided by Dr. Peter Backx (University Health Network Toronto, Ontario, 
Canada) for amplification at University of Michigan. The Ad-Nav1.5 construct was 
generously provided by Dr. Silvia Priori (University of Pavia, IRCCS Fondazione 
Maugeri, Pavia, Italy). 5 and 10 MOI were found optimal for Ad-Kir2.1 infection; 
10 and 20 MOI were found optimal for Ad-Nav1.5 infection. Viral infections were 
performed in NRVF at passage 3. All experiments, including patch clamping, 
fluorescence recovery after photobleaching (FRAP) and optical mapping, were 
performed at least 48 hours after infection to allow sufficient protein expression.  
3.3.3 Electrophysiology 
Voltage clamp experiments were performed in single ventricular NRVF 
infected with Ad-Kir2.1 or Ad-Nav1.5 using a MultiClamp 700B amplifier (Axon 
Instruments, Forest City, CA). IK1 recordings were carried out as previously 
described [88]. The bath solution contained (mM): NaCl 148, NaH2PO4 0.4, 
MgCl2 1, KCl 5.4, CaCl2 1, HEPES 15, pH was adjusted to 7.4 with NaOH. 
Nifedipine (5 µM) was added to block calcium currents. The pipette solution 
contained (mM): KCl 148, MgCl2 1, EGTA 5, HEPES 5, creatine 2, ATP 5, 
phosphocreatine 5, pH was adjusted to 7.2 with KOH. The tip potential was 
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nulled, cell capacitance and series resistance were compensated (~80%) and 
average cell size was calculated on the basis of cell capacitance (see Figure 
3.6). IK1 currents were elicited by 125 ms steps applied in 10 mV increments with 
a holding potential of 0 mV stepping from -100 mV to +50 mV. BaCl2 (1 mM) was 
used to isolate IK1 from background currents. INa was recorded at room 
temperature with the pipette filling solution (mM): NaCl 5, CsF 135, EGTA 10, 
MgATP 5, and HEPES 5 (pH=7.2). The extracellular solution contained (mM): 
NaCl 5, MgCl2 1, CaCl2 1, CdCl2 0.1, glucose 11, CsCl 132.5, and HEPES 20 
(pH=7.35). INa currents were recorded when membrane potential was 
depolarized from a holding potential of -160 mV to various potentials from -100 to 
10 mV in 5 mV increments and 200 ms duration.   
APs were recorded in the current clamp configuration using a MultiClamp 
700B amplifier from individual NRVF infected with Ad-Kir2.1 + Ad-Nav1.5, and 
Ad-Kir2.1 + Ad-Nav1.5 + Ad-Cx43. World Precision Instruments DS8000 
stimulator was used to generate square pulses (1 – 3 ms duration). Extracellular 
solution was HBSS with Ca2+ and Mg2+ (Sigma, MO). The pipette solution 
contained (mM): MgCl2 1, EGTA 5, KCl 150, HEPES 5, Phosphocreatine 5, 
K2ATP 4.5, β-Hydroxybutyric acid 2. All AP recordings were conducted at 37°C.  
3.3.4 Western Blotting  
Uninfected and Ad-Cx34 infected NRVF were lysed with RAPA buffer (50 
mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% NP-40, 0.25% Na-deoxycholate, 0.1% 
SDS, 1 mM EDTA) with protease inhibitor cocktail (Sigma, MO). 20 µg proteins 
were electrophoresed in 4-20% sodium dodecyl sulfate-polyacrylamide gel under 
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reducing condition, and proteins were transferred to polyvinylidene difluoride 
membrane. The membrane was incubated with rabbit anti-hCx43 antibody 
(Millipore, MA ) overnight at 4°C after being incubated in blocking buffer (5% fat-
free milk in Tris-buffered saline/Tween 20). After washing three times in TBST 
(100 mM Tris-HCl, pH 7.4, NaCl 145 mM, 0.1% Tween 20), the membrane was 
then incubated with horseradish peroxidase-conjugated goat anti-rabbit IgG 
(Jackson ImmunoResearch, PA). Chemiluminescence was developed by the 
addition of SuperSignal West Pico Chemiluminescent Substrate (Pierce, IL). 
Signals were detected using radiographic film. For re-probing, the membrane 
was incubated in Western Blot Stripping Buffer (Pierce, IL) for 30 min at 37°C. 
Then the membrane was re-blotted with mouse anti-GAPDH antibody and 
horseradish peroxidase-conjugated goat anti-mouse IgG (Santa Cruz Biotech, 
CA). 
3.3.5 FRAP experiments 
Uninfected and Ad-Cx43 infected (10 MOI) NRVF were loaded with 5-
(and-6)-carboxyfluorescein diacetate (5(6)-CFDA) (Invitrogen, NY) (7 µg/mL, 30 
min) at 37°C. Regular M199 culture medium was used for the dye loading and 
during experiments. Dishes were placed in a heating chamber to keep the 
temperature at 37°C. Singe cells were photobleached selectively using a 
confocal microscope and laser (Nikon A1R). Snapshots of fluorescence images 
were taken every 15 seconds until 6 minutes after the photobleaching. Target 
cells that went through photobleaching were marked with red circles (Figure 3.5). 
The cells next to the target cell were marked with green circles and used as 
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positive controls. The blue circles were set in the corner areas where no cells 
were present, in order to measure the background florescence. The recovery of 
florescence in the target cells was measured and normalized to the florescence 
right before the photobleaching. The time course of recovery of 5(6)-CFDA in 
target cells was fit with an exponential function using GraphPad Prism 5. The 
rate constant [166] and other parameters of the fitting were calculated and 
presented in table II.  
3.3.6 Optical mapping  
Monolayers were placed on a heating stage (37°C) and superfused 
constantly with non-carbonated HBSS (Sigma, MO) containing (mM): CaCl21.6, 
KCl 5.4, MgSO4 0.8, KH2PO4 0.4, NaHCO3 4.2, NaCl136.9, NaHPO40.3, D-
Glucose5.5, and HEPES10; pH 7.4. A high-resolution CCD camera (80x80 pixels, 
SciMeasure Analytical Systems Inc, GA) was used to record electrical wave 
propagation after staining the dishes with 40 µM/L di-8-ANEPPS (Molecular 
Probes, NY) for 15 minutes. Monolayers were paced at 2X threshold through a 
bipolar electrode. Incremental pacing started at 1 Hz (5 ms duration), until loss of 
1:1 capture or induction of sustained reentry. 5-s movies were obtained at 200 
frames/s and subsequently analyzed offline.  
3.3.7 Analyses of Optical Movies 
All movies were subjected to background fluorescence subtraction and 
filtered using spatial (3x3 pixels) and temporal (7 pixels) conical convolution 
filters. Phase maps were generated during sustained reentry to measure rotation 
frequency and phase singularities (PS) [76]. Dominant frequency (DF) maps and 
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phase maps were constructed as described previously [77]. DF and PS were 
calculated and averaged from each frame. For CV measurements, we conducted 
ensemble averaging for each pixel for over 5 or more propagating wave fronts 
following each stimulus. After generating an ensemble averaged movie the 
activation time distributions (50% of upstroke) for the spatial regions of 5x5 pixels 
were fitted with the plane, and gradients of activation times gx and gy were 
calculated for each plane along the x and y axes, respectively. Then we 
calculated the magnitude of the local CV for each pixel as (gx
2 + gy
2)-1/2. We then 
plotted mean values and standard deviations for CV. 
3.3.8 Statistical Analyses  
Statistical analyses were performed using Origin 6.0 and Prism 5. Two-
way ANOVA with Bonferroni post-tests was used for patch clamping and FRAP 
data. Analyses of rotation frequency and PS were performed using one-way 
ANOVA with Tukey’s multiple comparison test. A Student’s t-test with Welch-
correction was used to analyze the average CV. Data are expressed as 
mean±SEM. p<0.05 was considered to be significant.   
 
3.4 Results 
3.4.1 Kir2.1 and NaV1.5 expression in NRVF 
To our knowledge, constitutive expression of Kir2.1 has not been 
described for NRVF. At 5 MOI and 10 MOI of adenoviral Kir2.1 expression, we 
consistently observed uniform GFP expression in single NRVF, as illustrated in 
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Figure 3.1A. IK1 densities were determined by voltage-clamp experiments. Figure 
3.1B shows the voltage clamp protocol on the top right (see Methods session 
3.3.3) and representative Ba2+-sensitive IK1 traces on the top left. Cells were 
randomly selected for IK1 recordings. Both inward and outward IK1 increased 
when MOI was increased from 5 to 10 MOI. IK1 density vs voltage (IV) plots are 
shown on the bottom of Figure 3.1B. Both the peak inward and outward currents 
were significantly increased in 10 MOI (n=4) Ad-Kir2.1 infected NRVF comparing 
to 5 MOI (n=7) infected NRVF (-100 mV: -31.08±7.28 pA/pF vs. -13.83±6.12 
pA/pF, p<0.01; -50 mV: 22.22V±5.92 pA/pF vs. 3.34±0.92 pA/pF, p<0.01). 
Although the peak inward and outward currents in 5 MOI infected NRVF were still 
twice the amount of what reported previously in NRVM [167], we chose this MOI 
for the following monolayer experiments in order to keep a homogenous infection 
through a dish containing more than 200, 000 NRVF.   
Nav1.5 expression was achieved by infecting NRVF with Ad-Nav1.5 at 10 
MOI and 20 MOI. Average INa IV plots are presented in Figure 3.2A, with 
representative traces depicted on the top left and voltage-clamp protocol on the 
top right. Peak INa increased significantly when the MOI was increased from 10 to 
20 MOI (-21.64±6.64 pA/pF, n=8 vs. -81.27±25.41 pA/pF, n=4, p<0.001), 
reaching similar values as INa in native NRVM [168]. However, as expected 
normalized voltage dependence of activation and inactivation and recovery from 




3.4.2 Kir2.1 and NaV1.5 functional expression enabled AP generation in 
single NRVF 
As shown in the previous section, NRVF infected with Ad-Kir2.1 plus Ad-
NaV1.5 demonstrated robust INa and IK1 currents, which suggested that 
genetically engineered fibroblasts may become excitable and capable of 
generating APs. Thus, we co-infected three groups of NRVF with Ad-Kir2.1 and 
Ad-Nav1.5 (K/Na) at different MOI ratios: 10/10 (n=7), 10/20 (n=8), and 5/20 MOI 
(n=7), in an effort to optimize the conditions for excitability. The resting 
membrane potential (RMP) was hyperpolarized in all three K/Na  groups with 
respect to control, as illustrated in Figure 3.3A (p<0.05 vs. UI). In addition, as 
shown in Figure 3.3B, unlike control cells, current-clamp experiments enabled AP 
recordings from all three groups of co-infected NRVF. Quantification of the AP 
maximum upstroke velocity (dV/dtmax) in each of the three groups K/Na groups 
yielded values of 100 V/s on average. As summarized in Figure 3.3D-F, AP 
shapes were variable but in all cases repolarization phase showed a 
characteristic plateau-like morphology, owing to the strong inward rectification of 
IK1 at voltages between -50 and 0 mV (see Figure 3.1B) [169]. However, APD 
measured at 30, 50 and 80% repolarization were relatively brief in all three 
groups, with no statistically significant difference among groups.  
  
3.4.3 Cx43 overexpression increased coupling between neighboring NRVF 
Previous studies suggested that Cx43 was expressed in cultured cardiac 
fibroblasts [85]. Thus we used immunohistochemistry in confluent NRVF 
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monolayers to examine the level of Cx43 expression and thus determine whether 
APs would propagate across the monolayer. As shown by the left panel of Figure 
3.4A, Cx43 was nearly undetectable in uninfected NRVF monolayers. As 
expected, despite the fact that these monolayers expressed robust levels of both 
Kir2.1 and Nav1.5 they failed to propagate APs. Therefore, we constructed an 
adenovirus encoding human Cx43 sequence (Ad-Cx43) to overexpress Cx43 
proteins. The right panel of Figure 3.4A illustrates the outcome of using the Ad-
Cx43 construct. Cx43 was immunolocalized throughout on the cell membrane 
and also the nucleus area of myofibroblasts after 48 hours infection. Western blot 
results indicated that there is a more than 30-fold increase in total Cx43 expressions 
after infection (Figure 3.4B). 
 We used FRAP as a functional assay to determine whether 
overexpression of Cx43 increased cell-to-cell communication in the NRVF 
monolayer. Once loaded, the CFDA dye was retained in the cell because it was 
hydrolyzed by cytoplasmic esterases into carboxyfluorescein (CF). But it was 
able to permeate through gap junctions due to its low molecular weight (376 Da) 
[166]. Therefore, after photobleaching, unbleached dye molecules would 
redistribute to the target cell through gap junctions. Figure 3.5A shows 
representative recordings in a control NRVF monolayer v.s. an Ad-Cx43 infected 
NRVF monolayer, before and after the photobleaching. The target cells for 
photobleaching were outlined in red in both cases. After 6 minutes, fluorescence 
barely recovered in uninfected NRVF (n=4), suggesting weak intercellular 
coupling among normal NRVF. In contrast, Ad-Cx43 infected (n=3) NRVF 
showed a significant florescence recovery (>60%) after 6 minutes suggesting the 
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florescent dye was able to travel through the overexpressed Cx43 from the 
neighboring NRVF. Normalized florescence recovery plots were summarized in 
Figure 3.5B.  
3.4.4 K/Na/Cx43 overexpression enables fast AP propagation in NRVF 
monolayers 
Using 5 MOI Ad-Kir2.1 and 20 MOI Ad-Nav1.5, IK1 and INa current 
densities in NRVF reached similar levels as the corresponding values in NRVM 
(see Figures 3.1 and 3.2) [167, 168]. Also this triple infection significantly 
reduced input membrane resistance (106.85±51.07 MΩ, n=6 vs. 301.95±75.25 
MΩ, n=4, p<0.05) without changing the size of these NRVF (70.54±16.37 pF, 
n=6, vs. 117.74±33.09 pF, n=4, NS) (Figure 3.6). Therefore we chose this ratio in 
triple infection experiments to determine whether monolayers formed by excitable 
NRVF overexpressing Cx43 can propagate action potentials at velocities 
equivalent to those of myocytes. In triple infected NRVF (K/Na/Cx43 at 5/20/10 
MOI), we first confirmed that the cells were electrically excitable. Figure 3.7A 
illustrated representative AP recordings. A K/Na/Cx43 NRVF (Figure 3.7A left) 
generated large amplitude APs with rapid upstroke velocities, ~ 30 mV overshoot 
and ~ 40 ms duration similar to the morphology of the K/Na NRVF (Figure 3.3B). 
On the other hand, in the absence of NaV1.5, K/Cx43 NRVF (Figure 3.7A right) 
were unable to generate APs despite having a RMP of ~72 mV (Figure 3.7B). 
Thus the endogenous sodium current [170] was insufficient to depolarize the 
NRVF even with the stimulus bring the membrane potential to threshold. Figure 
3.7B shows that the RMP values for both K/Na/Cx43 (n=6) and K/Cx43 (n=5) 
85 
 
NRVF were similar to each other but significantly more negative than uninfected 
(n=3) NRVF. Figure 3.7C summarizes the values for APD30 APD50 and APD80 
measured at pacing cycle lengths between 250 and 1000 ms. The average 
APD80 at 1 Hz pacing was 37.13±7.78 ms in K/Na/Cx43 NRVF (n=4).  
To determine whether the overexpressed IK1 rather than the endogenous 
delayed rectifier potassium currents [170] was responsible for the AP shape 
during repolarization, we compared the effects of BaCl2 (1 mM) versus 4-AP (1 
mM) in single excitable NRVF. As shown in Figure 3.8A, while 4-AP (blue trace) 
did not affect either the AP shape or the RMP in any significant way, BaCl2 (red 
trace) initially prolonged APD and subsequently depolarized the RMP of the K/Na 
cells to the same level as the UI NRVF (gray trace). The effect of BaCl2 was fully 
reversed after a 5 min washout period (Figure 3.8B, n=4). Figure 3.8C and D 
summarizes the effect of 4-AP (1 mM, n=5) or BaCl2 (1 mM, n=4) on APD30, 
APD50 and APD80. While 4-AP did not modify APDs on all levels, BaCl2 
significantly prolonged both APD50 and APD80 (p<0.05 vs. control). 
In high resolution optical mapping experiments, K/Na/Cx43 NRVF plated 
as 2 dimensional (2D) monolayers, propagated action potentials at velocities 
(>20 cm/s) that were comparable to those of NRVM monolayers. Figure 3.9A is 
an activation map generated from an excitable NRVF monolayer paced at 1 Hz. 
Average CVs were quantified and plotted at varying pacing cycle lengths in 
Figure 3.9B. The average CV at 1 Hz was 20.71±0.79 cm/s (n=7). The optical 
APD75 and APD50 were also measured and summarized in Figure 5C.   
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3.4.5 Engineered excitable NRVF rescue CV in heterocellular monolayers 
Previously, we investigated the effects of myocyte-myofibroblast 
interactions on wave propagation dynamics in monolayers of co-cultured NRVM 
and NRVF [85]. We demonstrated that CV is diminished with larger 
myofibroblast/myocyte area ratios. To determine whether NRVF made excitable 
by K/Na/Cx43 overexpression can serve to rescue propagation,  we generated 
heterocellular monolayers consisting of randomly distributed mixtures of NRVM 
and excitable NRVF, and compared their properties with those of heterocellular 
monolayers containing unexcitable (i.e., uninfected) NRVF at the same 
myofibroblast/myocyte ratio (80% myocytes/20% fibroblasts). Figure 3.10A 
illustrates the random distribution of the two cell types at two different levels of 
magnification. In Figure 3.10B, we compare representative uninfected (control) 
and K/Na/Cx43 monolayers immunostained for α-actinin, Cx43 and DAPI. The 
expression of Cx43 at myocyte-to-fibroblast contacts was significantly increased 
in excitable NRVF monolayers comparing to control. Occasionally we were able 
to detect Cx43 and Cx40 between fibroblasts and myocytes, however, the overall 
expression of connexins is very limited (Figure 3.1C).  
Optical mapping was then performed in three groups of monolayers: pure 
myocyte (M) monolayers acting as control, heterocellular monolayers containing 
uninfected fibroblasts and myocytes (UI Fb/M), and heterocellular monolayers 
containing excitable K/Na/Cx43 fibroblasts and myocytes (K/Na/Cx43 Fb/M) at 
the same ratio (80% myocytes; 20% fibroblast). Figure 3.11A shows 
representative activation maps for each of the three groups of monolayers 
87 
 
obtained during pacing at 1 Hz. Clearly, conduction in the UI Fb/M monolayer 
(middle) was very slow compared to control (left). However, when the UI NRVF 
were replaced by the same number of excitable fibroblasts, the activation time 
was restored to the control level (right).  Composite results from 6-8 monolayers 
in each group are shown in Figure 3.11B. Quantification of CV at varying pacing 
cycle lengths demonstrated that the propagation velocities were significantly 
reduced in the UI Fb/M monolayers compared to control (21.18±0.65, n=6 vs. 
27.27±0.72 cm/s, n=8, p<0.05); however, excitable NRVF (K/Na/Cx43 Fb/M) fully 
restored fast CV (27.59±0.76 cm/s, n=8, NS vs M).  
 3.4.6 Engineered excitable NRVF rescued simple reentry patterns 
As demonstrated previously, increasing the proportion of fibroblasts in the 
monolayer reduced both CV and the frequency of reentry but increased the 
complexity of propagation during reentry resulting in fractionation, wavebreaks 
and increased number of wavelets [85]. Here we investigated whether the 
presence of excitable K/Na/Cx43 fibroblasts prevents such effects and restores 
the well-organized reentry patterns that are normally observed in monolayers 
containing >95% myocytes [77, 85]. Thus, we compared the dynamics of reentry 
in K/Na/Cx43 NRVF/M monolayers with those of UI NRVF/M and pure M 
monolayers. Sustained functional reentry could be observed in all three groups 
whether spontaneously or pacing induced. The top of Figure 3.12A shows phase 
maps obtained during reentry each of the three groups. In these maps,  each 
color indicates one phase of the AP, and the convergence of all colors at the 
center of rotation is defined as a phase singularity (PS) [151]. Under each phase 
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map is a corresponding time-space plot (TSP) constructed along the horizontal 
dashed line [171], to quantify the temporal evolution of the electrical activity in 
each monolayer. Consistent with our previous findings [85], the spatio-temporal 
characteristics of reentry were significantly more complex in the UI Fb/M 
monolayers (center) than in the M monolayer (left) or the K/Na/Cx43 NRVF/M 
monolayer. Clearly, the number of PS and the complexity of wave propagation 
were appreciably greater, but the frequency of reentry was significantly lower in 
the UI NRVF/M monolayer than in the other two. These data are consistent with 
the CV measurements plotted in Figure 3.12B. Figure 3.12B summarized the 
rotation frequencies from the three groups of monolayers. Clearly the UI NRVF/M 
monolayers had slower reentry frequency than control myocyte monolayers 
(6.81±0.32 Hz, n=10, vs 10.71±0.65 Hz, n=6, p<0.05). However, by increasing 
both excitability and intercellular conductivity, K/Na/Cx43 overexpression in the 
Fb/M monolayer restored the rotation frequency (10.35±0.28 Hz, n=11, NS vs M) 
to control levels. In Figure 8C the maximal number of PS was counted in each 
frame of a 5-s movie and the average was calculated and then plotted for each 
group [85]. As expected, the UI NRVF/M monolayers had a larger number of 
wavebreaks and PSs (6.54±1.16, n=10, vs 1.47±0.23, n=6, p<0.05) underlying 
increased complexity of AP propagation. Conversely, the number of phase 
singularities per frame in excitable K/Na/Cx43 Fb/M monolayers was similar to 




We have used a genetic engineering approach to convert unexcitable 
cardiac fibroblasts from neonatal rat hearts into excitable cells with the objective 
of restoring rapid impulse propagation in a heterocellular monolayer model. The 
most important results in Chapter 3 are as follows: 1. We generated excitable 
fibroblasts by adenoviral overexpression of three ion channels: Kir2.1, NaV1.5, 
and Cx43. 2. In patch clamp experiments, excitable NRVF demonstrated strong 
inward rectifier K+ currents that resulted in well polarized RMP near the predicted 
K+ equilibrium potential of -85 mV. These cells were readily excited by electrical 
stimuli similar to those used in NRVM in patch clamp experiments. When plated 
as 2D monolayers, these engineered excitable NRVF can propagate APs at 
velocities similar to those of NRVM. 3. In heterocellular (NRVM/NRVF) 
monolayers, engineered excitable NRVF rescued CV to a level similar to pure 
myocyte monolayers. 4. During reentry, both the complexity of wave propagation 
and the number of wavebreaks were significantly less in heterocellular 
monolayers containing excitable than non-excitable NRVF. Altogether, the data 
presented strongly suggest that, in the setting of cell therapy, safety of wave 
propagation and prevention of pro-arrhythmia can only be guaranteed by the 
ability of both donor cells and host myocardium to generate rapid upstroke action 




3.6 Study Limitations 
The engineered excitable NRVF were generated and examined in an in-
vitro neonatal rat model. While this allowed us to overexpress multiple ion 
channels in a highly controlled environment, the amount of virus required to 
make excitable NRVF could be different in large animals or humans because of 
the different expression of ion channels. Also we used uninfected NRVF instead 
of GFP infected NRVF in the co-culture system. In addition, adult myofibroblasts 
could be a better resource to further confirm our findings. Moreover, the 
adenoviral constructs of Kir2.1 used to increase IK1 was from mouse while the 
other two constructs were from human.  While this would be problematic for in 
vivo testing, our goal was to demonstrate feasibility in an in vitro system. 
Nevertheless, our data suggested that the excitable NRVF can rescue impulse 
propagation and reduce the incidence of complex arrhythmias in heterocellular 
monolayers formed by myocytes and myofibroblasts.  
 
3.7 Conclusion 
Genetically modified NRVF are capable of generating and propagating 
APs similar to those generated by NRVM. Moreover, excitable myofibroblasts 
can couple with host cardiac myocytes and reduce arrhythmia by restoring rapid 
conduction and reducing fibrillatory conduction. Altogether, the data presented in 
this study strongly suggest that, in the setting of cell therapy, safety of wave 
propagation and prevention of pro-arrhythmia can only be guaranteed by the 
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ability of both donor cells and host myocardium to generate rapid upstroke action 
potentials and propagate them at high velocities. 
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Table I - Cell size of NRVF and NRVM  
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One-phase association Control  Ad-Cx43 
Best-fit values     
Y0 -52.65 -19.86 
Plateau 5.952 54.95 
K 4.145 0.9122 
Tau 0.2412 1.096 
Half-time 0.1672 0.7599 
Span 58.60 74.81 
Std. Error     
Y0 37.23 2.888 
Plateau 0.2479 0.4700 
K 1.046 0.04464 
Span 37.18 2.702 
95% Confidence Intervals     
Y0 -128.9 to 23.61 -25.85 to -13.87 
Plateau 5.444 to 6.460 53.98 to 55.93 
K 2.003 to 6.288 0.8196 to 1.005 
Tau 0.1590 to 0.4993 0.9952 to 1.220 
Half-time 0.1102 to 0.3461 0.6898 to 0.8457 
Span -17.55 to 134.7 69.21 to 80.42 
Goodness of Fit     
Degrees of Freedom 28 22 






Figure 3.1. Adenoviral expressions of Kir2.1 and NaV1.5 proteins in NRVF 
after 48 hours of infection. A. GFP-tagged Kir2.1 channel expression. Left: 
fluorescent micrograph of a passage 3 NRVF 48 h after Ad-Kir2.1 infection. 
Right: corresponding phase contrast micrograph. Scale bar = 100 µm. B. Voltage 
clamp protocol (top right) and representative example of currents (top left) from 
Ad-Kir2.1  infected NRVF; and I-V relationship (bottom) of the BaCl2 sensitive 
currents normalized to cell capacitance in NRVF infected with Ad-Kir2.1 at 5 MOI 




Figure 3.2. Adenoviral expressions of Nav1.5 proteins in NRVF after 48 
hours of infection. A. Voltage clamp protocol (top right) and representative 
examples of currents from Ad-Nav1.5 (top left) infected NRVF; and I-V 
relationship (bottom) of INa normalized to cell capacitance in NRVF infected with 
Ad-Nav1.5 at 10 MOI (filled circles) and 20 MOI (open circles). B. Normalized 
activation and inactivation curves of INa. C. Normalized recovery from inactivation 





Figure 3.3. Characterizations of action potentials in NRVF co-infected with 
Ad-Kir2.1 and Ad-Nav1.5 (K/Na). A. Resting membrane potentials from 
uninfected and co-infected NRVF (K/Na: 10/10, 10/20 and 5/20 MOI). B. 
Representative action potential recordings from NRVF infected with K/Na at 
10/10, 10/20 and 5/20 MOI. C. Maximal upstroke velocity measured from co-
infected NRVF (10/10, 10/20 and 5/20 MOI, NS). D- F. Action potential durations 
(APD)80, APD50 and APD30 in co-infected NRVF (10/10, filled circles; 10/20, open 



















Figure 3.4. Adenoviral expressions of Cx43 in NRVF after 48 hours of 
infection. A. Immunostainning of control and Ad-Cx43 infected NRVF using an 
antibody for Cx43 (green) shows increased expression of Cx43 on cell 
membrane. Scale bar = 50 µm. B. Western blot showing Cx43 expression was 







Figure 3.5. Functional coupling in uninfected and Ad-Cx43 infected NRVF. 
A. FRAP experiments shows strong functional coupling between Ad-Cx43 
infected NRVF. Red box indicated the target cell that was photobleached. Green 
box shows the possible donor cell next to target cell. Blue and yellow box were 
used to evaluate the background fluorescence. B. Quantification of the 
florescence recovery six minutes after photobleaching in control (open circles) 






Figure 3.6. Characterizations of cell membrane properties. A. Comparison of 
cell capacitances between cardiac fibroblasts and NRVM. B. The viral infection 
did not change the capacitances of NRVF. C. The viral infection significantly 








Figure 3.7. Characterizations of action potentials in NRVF infected with Ad-
Kir2.1, Ad-Nav1.5 and Ad-Cx43. A. Action potentials were recorded from triple 
infected (K/Na/Cx43, 5/20/10 MOI) NRVF (left) but not in K/Cx43 (5/10 MOI) 
infected NRVF (right). B. Resting membrane potentials in uninfected, K/Na/Cx43 
infected and K/Cx43 infected NRVF. C. APD80, APD50 and APD30 measured at 






















Figure 3.8. Effect of BaCl2 and 4-AP on action potentials in NRVF infected 
with Ad-Kir2.1, Ad-Nav1.5 and Ad-Cx43. A. Representative AP traces shows 
that resting membrane potential and APD are sensitive to BaCl2 (1mM) but not 4-
AP (1mM). B. RMP measured before and after BaCl2 (1mM) perfusion and after 
washout in K/Na/Cx43 NRVF. *: p<0.05. C. Quantification of APD30, APD50 and 
APD80 before and after 4-AP or BaCl2 perfusion. D. Quantification APD30, APD50 




Figure 3.9. Action potential propagation in 2D monolayer of K/Na/Cx43 
NRVF. A. Representative activation map of electrical paced (1Hz) AP 
propagation in K/Na/Cx43 NRVF monolayer. Scale bar =10 mm. B. CV of 
paced propagation at different pacing cycle lengths from 1000 ms to 200 ms 
(n=7). C. APD75 and APD50 measured at different pacing cycle lengths from 1000 




Figure 3.10. Interaction of NRVF and NRVM in an in vitro heterocellular 
monolayer model. A. Coimmunostainning of NRVM/NRVF co-culture using an 
antibody for a-SMA (red) and an antibody for a-actinin (green). Scale bar = 10 
µm. B.  Characterization of Cx43 expression between NRVF and NRVM in 
heterocellular monolayers (uninfected NRVF vs. K/Na/Cx43 NRVF). Scale bar = 
50 µm. C. Cx43 and Cx40 expression in UI Fb/M heterocellular monolayer. 





Figure 3.11. K/Na/Cx43 NRVF rescued normal conduction velocity. A. 
Activation maps from monolayers of myocytes only (M, left), 20% uninfected 
NRVF/NRVM co-culture (UI Mf/M, middle), and 20% K/Na/Cx43 NRVF/NRVM 
co-culture (KNaCx43 Mf/M, right). B. Quantification of CV at varies pacing cycle 
lengths in monolayers of myocytes (filled circles), 20% UI co-culture (open circle), 




Figure 3.12. K/Na/Cx43 NRVF increased reentry frequency and reduced 
wavebreaks. A. Snapshots (top) and Time-Space Plot (bottom) from 
representative optical mapping movies in monolayers of myocytes (left), 20% UI 
co-culture (middle), and 20% engineered co-culture (right). B. Quantification of 
rotation frequency in monolayers of myocytes (filled circle), UI co-culture (open 
circle), and engineered co-culture (filled square). C. Quantification of phase 
singularities in monolayers of myocytes (filled circle), UI co-culture (open circle), 







In general, the work presented in this dissertation can be divided into two 
similar, and yet, very different projects. One common feature between them is 
that both projects utilized a 2-dimensional (2D) biological tissue model, each 
tailored for the specific goals of the given study. First, using NRVM monolayers, I 
investigated the effects of overexpressing hERG (IKr) on electrical impulse 
propagation and reentry dynamics in this cardiac cellular model. Second, I 
created a new model by engineering cardiac fibroblasts so that they could serve 
as excitable donor cells. I then studied the efficacy and consequences of using 
these cells to restore rapid impulse propagation and to reduce the initiation of 
reentry arrhythmia in monolayers.  
The most important results of my first project (hERG/IKr upregulation) are 
described in detail in Chapter 2 of this dissertation. In brief, the key 
electrophysiological findings, with respect to the NRVM monolayer model, are as 
follows: 1) IKr overexpression significantly increased the frequency of reentry; 2) 
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Under conditions of low frequency pacing (1-5Hz), IKr overexpression shortened 
the APD by more than 50%, but it did not affect CV; 3) During sustained reentry, 
APD shortening (induced by IKr upregulation) resulted in a reduced WL with 
increased CV values at all distances from the rotor’s core. The shorter WL and 
higher CV provided the appropriate environment for fast and stable rotors; 4) 
Computer simulations showed that the mechanism underlying IKr-induced rotor 
acceleration is a transient hyperpolarization following the repolarization phase of 
each AP, and this increased sodium channel availability, and thus excitability 
ahead of the wave front. 5) The transient hyperpolarization was confirmed 
experimentally in current-clamp studies with single NRVM infected with Ad-
HERG. Overall, the results presented in this study (Chapter 2) provide strong 
evidence that hERG overexpression dramatically accelerates reentry frequency 
by shortening the APD and transiently hyperpolarizing the cell membrane 
potential. Therefore, it is plausible to suggest that an increase in IKr could be an 
important factor in the maintainance of cardiac arrhythmias.
The most important results of my second project are presented in detail in 
Chapter 3 of this dissertation. In summary, the key results are as follows: 1) 
Excitable cardiac fibroblasts were successfully generated by adenoviral 
overexpression of three ion channel proteins: Kir2.1, NaV1.5, and Cx43. 2) In 
patch clamp experiments, excitable NRVF demonstrated strong inward rectifier 
K+ currents that resulted in a well-polarized RMP near the predicted K+ 
equilibrium potential of -85 mV. These cells were readily excited by electrical 
stimuli similar to those used for NRVM in patch-clamp experiments. When plated 
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as 2D monolayers, the engineered, excitable NRVF propagated APs at velocities 
similar to those recorded for NRVM. 3) Compared to monolayers containing 
unexcitable fibroblasts alone or with NRVM, heterocellular (NRVM/NRVF) 
monolayers that contained the engineered excitable NRVF were able to rescue 
the CV to a level similar to that observed with pure myocyte monolayers. 4) 
During reentry, both the complexity of wave propagation and the number of 
wavebreaks were significantly less in heterocellular monolayers containing 
excitable NRVF as compared to those with non-excitable NRVF. Altogether, the 
results presented in Chapter 3 support the concept that cell therapy would benefit 
from using electrically excitable donor cells as a way to increase the safety of 
wave propagation and thereby reduce the arrhythmogenic potential associated 
with fibrosis and other pathological conditions.  
 
4.1 The Role of hERG in Arrhythmias 
To date, more than 300 mutations have been identified that are associated 
with a loss-of-function phenotype in IKr and LQTS2 [150]. These mutations result 
in suppression of hERG channel function, either due to impaired trafficking of the 
channel subunits or a result of dominant negative effect of the channels on the 
cell membrane. However, gain-of-function mutations in IKr can be arrhythmic as 
well. For example, a hERG-linked short-QT syndrome (SQTS) has been 
described, in which an inactivation-attenuating mutation, N558K, resulted in a 
gain-of-function in hERG channels [98, 157].   It is now generally accepted that 
loss-of-function in hERG channels results in prolongation of the APD, which 
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increases the incidence of EADs and enhances the spatial heterogeneity of AP 
repolarization (a substrate for wavebreaks and reentrant arrhythmia) [172]. 
However, the mechanism of how a gain-of-function mutation in hERG can lead to 
arrhythmias is unclear. 
4.1.1 A dual mechanism for IKr-overexpression-induced rotor acceleration  
While the clinical phenotypes associated with alterations in potassium 
channels have been characterized for years, it was unknown how those 
alterations affected reentry frequency and dynamics. The results presented in 
Chapter 2 suggest that the consequences of IKr overexpression are somewhat 
similar to those recently demonstrated for the ventricles of transgenic mice 
overexpressing the inward rectifier potassium channel (IK1), which resulted in a 
shorter WL, sustained membrane hyperpolarization and exceedingly fast and 
stable reentry/VF [76]. In the same study, computer simulations established that 
during sustained reentry the diastolic membrane potential was 4 mV more 
negative (~−94 mV) in the transgenic when compared to the WT case (~−90 mV). 
Such hyperpolarization was enough to increase the Na+ channel availability by 
~30%, which contributed to reducing the core size and stabilizing the reentry. 
Similar to the IK1 overexpressing mouse, our IKr overexpressing monolayers also 
resulted in APD and WL shortening. However, unlike the transgenic IK1 
overexpressing mouse, the hyperpolarization associated with IKr overexpression 
was transient and the membrane potential returned to the resting level within 100 
msec or less. Therefore, a relative increase in CV was manifested during high 
frequency reentry, but was undetectable at the lower pacing frequencies.  
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Nevertheless, as demonstrated by additional computer simulations 
presented in Figure 2.13, increase in Na+ channel availability at the time of 
maximal hyperpolarization would certainly contribute to increase the CV (Figure 
2.14), and therefore the frequency and stability of the rotors, and to reduce the 
incidence of wavebreak and fibrillatory conduction. Initially, this result was 
unexpected because up-regulation of the other component of the delayed 
rectifier K+ current, IKs, has been shown to contribute to post-repolarization 
refractoriness, and to increase the incidence of wavebreaks and fibrillatory 
conduction with only a modest increase in rotor frequency [77]. Yet, as 
demonstrated in the computer simulation (Figure 2.13), while IKr upregulation 
produced a transient hyperpolarization after the abbreviated action potential,  IKs 
upregulation  did not result in membrane hyperpolarization and therefore its 
effects on INa availability were substantially blunted at any given activation 
frequency. The difference is most significant at the highest frequencies which are 
relevant to those usually observed during reentry in the monolayers. Our 
additional computer simulations presented in Figure 2.14 with MDPs clamped to 
less negative potentials in single cell, 1D cable and 2D monolayer models further 
confirm that the transient hyperpolarization contributes to the acceleration of 
reentry in IKr upregulation. Note that the effects of increased INa availability and 
CV disappeared when the transient hyperpolarization was artificially suppressed. 
4.1.2 Different IKr vs IKs kinetics, different consequences during reentry 
Although initially counterintuitive, the results presented in Chapter 2 add 
up when one considers the different kinetics of IKr and IKs, as well as their 
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different contributions to repolarization during the cardiac AP. IKr activates rapidly 
and displays marked inward rectification due to the fact that, at positive 
membrane potentials, the rate of IKr inactivation is faster than the rate of IKr 
activation. Consequently, IKr has a relatively low conductance during the AP 
plateau (phase 2) but continues to increase throughout a substantial portion of 
the repolarization phase (Figure 2.13A), which explains the marked APD 
shortening and transient hyperpolarizing effects of IKr overexpression in our 
NRVM. In contrast, although IKs increases somewhat more rapidly during the 
plateau, it begins to decline before phase-3 repolarization takes place (Figure 
2.13B). As such, IKs contributes relatively less than IKr to the repolarization phase 
of the ventricular AP; and thus, its APD shortening effect is relatively less than IKr 
at any given level of up-regulation. Taken together with the fact that IKs up-
regulation does not lead to transient hyperpolarization after each AP, this helps 
to explain the substantially lesser effect of IKs up-regulation on rotor frequency in 
the monolayers as compared with IKr up-regulation. As demonstrated previously, 
because of its slow deactivation kinetics, IKs tends to accumulate at high 
frequencies, and it therefore plays an important role in post-repolarization 
refractoriness and fibrillatory conduction [77, 173, 174]. In contrast, during reentry, 
the shorter APD produced by IKr-overexpression gives Na
+ channels enough time 
to recover, without impinging on the excitability during the diastolic interval before 
the next wavefront invades the tissue. As a result, this prevents wave front-wave 
tail interactions that could destabilize the rotor. In addition, the transient 




availability and excitability, both of which are very sensitive to the membrane 
potential. Finally, IKr is not known to accumulate like IKs does, which suggests that 
IKr is unlikely to play any important role in postrepolarization refractoriness. This 
would also explain why, in the IKr-overexpressing monolayers, rotors are able to 
spin at very high frequencies without breaking apart. 
While this mechanistic understanding of how potassium currents influence 
arrhythmogenesis is important, more often ventricular arrhythmias occur after a 
gross anatomical insult [175]. The result of these insults is the infiltration of the 
damaged myocardium by fibroblasts and the replacement of viable myocardium 
with fibrosis. However, gene therapy may allow a pathogenic response to an 
insult to be a viable therapy one day. 
 
4.2 Genetic modification of cardiac fibroblasts 
To date, the only published genetic modifications aimed at converting 
unexcitable cells into fully excitable cells have been conducted using HEK293 
cells. In 2005, Cho et al. attempted to generate pacemaker cells from HEK293 
cells by expressing three ion channels: Kir2.1, NaChBac (a Na+ channel from 
bacteria), and the human ether-a-go-go (hERG)-related channel. APs were 
generated in a small number of these cells (5/31) with a low maximum rate of rise 
of 21.6±8.6 V/s [176]. More recently, in 2011, Kirkton et al. generated a stable 
line of excitable HEK293 cells by modifying the combination of overexpressed 
proteins, delivering Kir2.1, Nav1.5, and Cx43 proteins into the cells [86]. In a 
subsequent study, the same group showed that these excitable HEK293 cells 
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improved both the electrical and mechanical function of a “zig-zag” network of 
cardiac tissues in vitro [177]. However, to our knowledge there is no previously 
published evidence of similar genetic modifications in unexcitable cells of cardiac 
origin prior to this dissertation. 
4.2.1 Why Kir2.1, NaV1.5 and Cx43 overexpression in NRVF? 
Excitable NRVF generated APs whose morphology was reminiscent of 
APs in mammalian ventricular myocytes. However, in all cases, the APD 
measured at 80% repolarization was relatively brief. Only early during Ba2+ 
superfusion was the APD80 prolonged to about 200 msec, and this immediately 
preceeded complete Ba2+-induced depolarization (Figure 3.8A). During the first 
few minutes of Ba2+ superfusion, the excitable NRVF were slightly depolarized 
and demonstrated a prominent plateau, which likely represented the time course 
of INa inactivation in the presence of strong inward rectification of IK1 [169]. 
Nevertheless, the question still arises as to whether the endogenous sarcolemma 
ion channels in the NRVF contributed to the AP morphology that was observed 
under our experimental conditions. What is known is that three endogenous 
voltage-gated potassium currents have been identified and characterized in 
NRVF: Ito, IKf and IKs [170]. The distribution of these potassium channels is very 
heterogeneous, but the transient outward K+ current (Ito) is expressed in majority 
of cells; two different delayed rectifier K+ currents (IKf and IKs) are expressed in a 
small percentage of cells. In addition, 4-Aminopyridine (4-AP) was found to 
strongly block IKf and IKs while it had no effect on Ito. As demonstrated in this 
dissertation (Chapter 3), 4-AP blockade had negligible effects on the APD of 
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excitable NRVF, which suggests that neither IKf nor IKs was involved in 
repolarization. It is possible that Ito may have at least a minor contribution during 
the early phase of repolarization, but it is unlikely that this current has any 
significant role in maintaining the highly polarized resting membrane potential.   
Walsh et al. also identified a small tetrodotoxin-sensitive Na+ current in 
some cells (NRVF) [170]. However, we observed that in the absence of NaV1.5 
overexpression, this small endogenous Na+ current was unable to depolarize 
cells beyond threshold for AP initiation despite Kir2.1 overexpression, and a cell 
RMP that was close to -80 mV (Figure 3.7A).  In a separate study, Na+-Ca2+ 
exchanger mRNA and proteins (NCXI) were identified, which may play a role in 
restoring the Na+ gradient in our engineered NRVF [178].  
With respect to intercellular communication, studies have suggested that 
NRVF express gap junction proteins (Cx43, Cx45 and Cx40) across a number of 
species [133, 140, 179]. However, our immunostainning results indicated that 
expression of either Cx43 or Cx40 was very limited in control NRVF (Figure 3.4 
and 3.10C). Therefore, although Ad-Kir2.1 + Ad-NaV1.5 infection made NRVF 
excitable, we were unable to demonstrate AP propagation in monolayers 
consisting of excitable NRVF that only expressed native connexion proteins at 
endogenous (low) levels. However, excitable NRVF monolayers which also 
overexpressed Cx43 exhibited wave propagation at velocities comparable to 
those of NRVM. Therefore, our results suggest that, in the setting of cell therapy,  
a sufficient density of gap junctional current would be necessary to enable AP 
propagation between excitable donor cells and the host myocardium.  
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Our results significantly extend those of McSpadden et al. [164], who 
conducted a study on cell pairs, in which each pair consisted of a NRVM coupled 
to an engineered unexcitable HEK293 cell of varying size expressing 
Kir2.1+Cx43. They demonstrated that pairing a large unexcitable HEK293 cell 
(e.g., ~30 pF) to a NRVM reduced the myocyte RMP and distinctly impaired its 
ability to generate action potentials. On the other hand, a smaller HEK293 cell 
size and the presence of IK1 contributed to the preservation of the NRVM RMP, 
as well as the excitability of the myocyte and the normal shape of its action 
potential. The myofibroblasts used in the present study (~82 pF at passage 3) 
were larger than the HEK cells (~31 pF) used by McSpadden et al.. Additionally, 
our myofibroblasts were also significantly larger than the NRVM (~12 pF).  Yet, 
the presence of NaV1.5 in the myofibroblasts not only helped preserve the ability 
of the myocytes to generate action potentials but it did so with a high degree of 
safety. This was demonstrated by the significantly larger conduction velocity of 
heterocellular monolayers containing excitable myofibroblasts as compared to 
monolayers containing unexcitable myofibroblasts. We can thus infer that, in the 
setting of cell therapy, the safety of wave propagation and prevention of pro-
arrhythmia can only be guaranteed by the ability of both donor cells and host 
myocardium to generate and propagate rapid upstroke APs.  
4.2.2 NRVF as a target to treat post MI arrhythmia 
Several laboratories have developed a number of in vitro models to study 
the interaction(s) between NRVF and myocytes as well as their role in modifying 
impulse conduction and arrhythmia [133, 134]. Rohr’s group significantly 
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advanced our understanding of the consequences of heterocellular coupling 
using patterned strands [134]. Gaudesius et al. provided strong evidence that 
NRVF inserted between strands of NRVM could lead to significant conduction 
delay, and even conduction block, when the length of the NRVF exceeded 300 
µm [134]. Subsequently, using a different heterocellular arrangement in their co-
cultures, Miragoli et al proved that the incidence of ectopic activity was in direct 
relationship with the density of NRVF cultured on top of the myocyte strands 
[133]. Experimental and computer simulation results from our laboratory 
demonstrated that in heterocellular monolayers containing fibroblasts distributed 
at random, the conduction velocity exhibits a complex nonlinear dependence on 
the degree of electrical coupling [85]. Taken together, all of the above evidence 
emphasizes the importance of the fibroblast as a potential target to regulate 
normal and abnormal impulse propagation and arrhythmogenesis in the fibrotic 
myocardium in vitro.  
Recently, Rosker et al. tested the ability of three individual drugs to revert 
the phenotype of myofibroblasts to fibroblasts in cultured conditions [145]. They 
reported that 24 hour-treatment with an actin-targeting drug abolished the 
NRVF’s arrhythmogenic interaction with cardiomyocytes by increasing the CV in 
a dose-dependent manner [145]. More recently, Jayawardena et al. 
demonstrated that fibroblasts can be reprogramed to cardiomyocytes using a 
combination of only four micro-RNAs in vitro and in vivo [180]. This finding alone 
further emphasizes the importance, and feasibility of using NRVF as a 
therapeutic target to regulate cardiac electrical activity post MI. In this 
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dissertation, I tested another approach, and genetically modified NRVF using a 
combination genes coding for three distinct membrane proteins that are essential 
in the initiation and propagation of cardiac electrical impulses. This gene therapy 
enabled us to successfully improve conduction and prevent the arrhythmogenic 
effects of fibrosis in an in vitro model. 
 
4.3 Cell Therapy to Treat Arrhythmias  
Despite varying success of conventional therapies (pharmacology, 
ablation, and electronic devices) in the treatment of cardiac arrhythmias, cell 
therapy has recently become a strong focus of many laboratories. Multiple cell 
types have been tested and introduced into host tissue with the hope of repairing 
damaged or compromised cardiac tissues by aiming to improve impulse 
conduction and contractility of the host myocardium [176].  
4.3.1 Gene/Cell therapy for cardiac arrhythmias 
Recent studies have shown that human mesenchymal stem cells (hMSCs) 
overexpressing HCN2 channels can serve as biological pacemakers when they 
form gap junction-mediated electrotonic coupling with host cardiomyocytes [181]. 
Injection of these hMSCs into the left ventricular wall successfully induced 
spontaneous rhythms in a chronic canine model of atrioventricular block [161]. 
Another recently developed technique utilized polyethylene glycol to induce cell 
fusion and create heterokaryons of donor and host cells. By using cell fusion, the 
authors avoided uncontrolled migration of donor cells and the need for high 
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degree gap junction coupling in order to obtain functional effects. Heterokaryons 
of host myocytes and HCN1-overexpressing fibroblasts have been shown to 
generate spontaneous AP oscillations in guinea pig hearts [160]. These in vivo 
heterokaryons were shown to remain stable in the host heart for several months 
[182, 183]. Human embryonic stem cells (hESCs) have also been efficacious at 
modulating heart rate. hESCs derived cardiomyocytes can differentiate into 
embryoid bodies (EBs) that can couple with NRVM and serve as biological 
pacemakers [184]. However, the in vivo effects of these pacemakers are still 
controversial. Importantly, while most cellular therapies have thus far aimed to 
modulate pacemaking, very few have been developed toward rescuing impulse 
propagation across diseased or scar tissue.  
4.3.2 Choice of NRVF as a candidate for cell therapy 
Being the most abundant cell type in the heart, cardiac fibroblasts, and 
their differentiation into myofibroblasts, have been a huge topic of post MI 
arrhythmia research [123]. Myofibroblasts have been identified in mature human 
infarct scars 17 years post-infarction [185, 186]. These cells contribute to the 
development of cardiac fibrosis. They accomplish this by consolidating the 
infarcted tissue and depositing excess ECM components [187]. Although cardiac 
MF maintain the myocardium structure in the diseased heart [188], they also 
promote arrhythmias through multiple mechanisms. Fibroblasts release various 
cytokines that alter the expression of various ion channel proteins in 
cardiomyocytes [189]. Also, they might modify the electrophysiology of the 
myocardium by coupling to the surviving myocytes.  
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A recent study has provided evidence that engrafted fibroblasts can 
integrate with host cardiomyocytes after transplantation in both small and big 
mammalian models (rats and pigs) [163]. This has paved the path for the 
development of a combination gene cell therapy aimed at improving conduction 
in myocardium with fibroblast infiltration. Therefore, the genetic modification 
approach developed in Chapter 3 may serve as a foundation for novel 
therapeutic avenues targeting gene regulation of cardiac fibroblasts. Further, 
excitable MF may play a key role in future cell therapy where they can be used to 
replace damaged cardiac cells in infarcted tissues. 
4.3.3 Engineered MF vs. stem cell derived cardiac myocytes 
Human induced pluripotent stem cell (iPS) derived cardiac myocytes have 
recently become another main focus of cell therapy, with the long-term hope that 
they may be introduced into host tissue and restore lost myocytes function 
following MI. Our laboratory has successfully constructed in vitro monolayers of 
human iPS-derived cardiac myocytes (iPSC-CMs) to study impulse propagation 
and reentry arrhythmias [82]. Simultaneous voltage and calcium mapping 
showed that iPSC-CM monolayers propagate APs at CVs that are comparable to 
those recorded in NRVM monolayers [190]. As a potential therapeutic avenue, 
these cells hold great promise for two main reasons: (1) the ability of researchers 
to obtain patient-specific iPSC-CMs; (2) the inherent nature of iPSC-CMs to 
undergo unlimited cell reproduction. To my knowledge, iPSC-CMs have not yet 
been successfully used for cardiac regeneration, althrough significant advances 
have been made toward understanding and characterizing these cells so as to 
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better facilitate their continued and future role in basic research and medicine. 
Human iPS-CMs were first reported to have a slow upstroke velocity (8~10 V/s), 
likely due to their less negative RMP (-63.5 and -57.1 mV) [191, 192]. Injection of 
stem cells, however, has thus far yielded mixed results in in vivo animal studies. 
Although slight improvements have been observed, only a very small percentage 
of injected iPSC-CM cells have been shown to survive after implantation [193, 
194]. Therefore, though promising, the field of cardiac regeneration is in an infant 
stage and still requires a great deal of fundamental basic research before it could 
be translated into clinical practice. One area of needed research includes 
experiments in which excitable MF, similar to those generated in our own study, 
are allographicaly implanted in the infarcted hearts of animals. The short and 
long-term results from such a study would likely provide vital insights into the 
potential benefits/challenges associated with this type of cell therapy. In theory, 
the idea is novel and of great potential clinical significance: replace scar tissue 
with (new) cells, cells that are capable of generating APs and possibly forming 
connections with surviving border zone myocytes. However, the feasibility, 
efficacy, and long-term benefits/consequences of this idea still need to be 
thoroughly tested in practice. 
MF also offer benefits that may be unique to those predicted from the use 
of stem cells. In addition to providing a potential conductive pathway, excitable 
MF may also aid in the formation of 3D collagenous structures that support 
cardiomyocyte attachment and alignment. As research in the field of regenerative 
medicine progresses, it may be found that there is a need, or benefit, to introduce 
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both excitable MF and iPSC-CMs. In such a way, combined therapy might be of 
experimental (and ultimately of clinical) interest. By using excitable MF in 
combination with stem cell derived cardiomyocytes, it may be possible to 
facilitate the formation of cell patches or sheets, which could be implanted into 
the fibrotic myocardium in order to help improve propagation and contractility. 
 
4.4 Future Directions 
As discussed above and throughout this disseration, my doctoral studies 
have demonstrated that wild type hERG overexpression results in fast reentry 
that contributes to the maintenance of high frequency arrhythmia. However, the 
mechanism(s) to explain how gain-of-function mutations (i.e. N588K) of the 
hERG channel can modify impulse propagation and the dynamics of reentrant 
arrhythmia is still not completely understood. In contrast to what is observed with 
protein (channel) overexpression, the number of hERG channels on the cell 
membrane does not increase on account of the N588K mutation. Instead, this 
gain-of-function mutation appears to change the gating properties of hERG, 
specifically the inactivation process of the channel. It is tempting to speculate that 
wild type hERG overexpression and hERG gain-of-function mutations may have 
some similar effects on the morphology of the cardiac AP (e.g. short APD); yet, 
how N588K hERG channel expression alters impulse propagation and reentry 
remains unclear, and can only be addressed with further study. The N588K 
mutation has been reported to have mixed gain- and loss-of function 
consequences for IKr [195]. In voltage clamp experiments, Grunnet et al. 
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observed both an increase in peak current and a reduction in tail current [195]. 
AP clamp experiments revealed that, unlike wild type hERG channels, 
expression of N588K hERG channels generates a bell-shaped current whose 
peak conductance occurs early in the plateau phase of the AP. The shift 
observed in hERG kinetics on account of the N588K mutation may result in a 
profound shortening of the APD. However, an important question  arises that is 
central to both understanding hERG channel function and my doctoral studies: 
does expression of mutant channels that result in hERG/IKr gain-of-function leads 
to a transient hyperpolarization, similar to that observed  with  overexpression of 
wild type hERG channels (Chapter 2)? If so, how does this transient 
hyperpolarization contribute to normal and abnormal impulse propagation? 
Investigating the aforementioned gain-of-function mutation of hERG channels will 
provide valuable information on the specific mechanisms underlying short QT 
syndrome (SQTS) related mutations and their role in controlling the dynamics of 
arrhythmia. For continued study of N588K hERG channels, an in vitro model 
such as NRVM monolayers would serve as a beneficial tool, as used and 
described in Chapter 2. Human iPSC-CMs monolayers (>15 mm in diameter), 
such as those recently developed in our laboratory, would also aid in these 
studies and additionally close the gap to clinical application (considering the 
human origin of the cells) [190]. Overall, the hiPSC-CM model could serve as a 
powerful tool to study a variety of known cardiac mutations in a human in vitro 
system. With respect to SQTS, one could study the molecular and 
electrophysiological effects of mutations in different channel proteins using the 
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same biological model. For example, the same cell and experimental design 
could be used to investigate the effects/properties of N588K in KCNH2, as well 
as of mutations specific for KCNQ1 and KCNJ2 (two other common SQTS-
related genes). Finally, in vivo animal models of SQTS mutations should be 
developed in order to better evaluate how these potassium channel mutations 
influence impulse propagation under physiological and pathophysiological 
conditions at the 3-dimensional level. 
Another important outcome of this thesis work is that the included studies 
provided a “proof of concept” that inclusion of excitable cells, such as those 
derived from a fibroblast lineage, may be a promising therapy in the prevention of 
arrhythmia in post-MI myocardium. The results further suggest that inclusion of 
these excitable cells is likely to be a more appropriate option than using 
unexcitable cells as a means of preventing pro-arrhythmia. Although I 
demonstrated that engineered excitable MF were able to improve conduction and 
reduce arrhythmia complexity, one should of course use caution before 
extrapolating these data to human clinical practice. It should be noted that 
introducing MF, let alone additional MF, into the atria or ventricles may be risky 
for a number of reasons, including: (1) inherent immunogenic response of 
injection/inclusion of foreign cells; (2) MF are known to  increase extracellular 
matrix generation; and (3) MF secrete   various cytokines that may up- or down-
regulate ion channel expression in the host myocardium, all of which may have 
unique and potentially damaging effects. Therefore, genetic modification of 
endogenous cardiac MF, without introduction of additional myofibroblasts, would 
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be a more appropriate therapeutic approach. One way this could be achieved is 
to inject the specific viral constructs directly into the myocardium that has the MF 
infiltration. However, before any viral vectors are injected into myocardium 
(injured or not), a full characterization needs to be conducted so as to assess the 
safety and effects of expressing these ion channels in NRVF in vivo. One can 
speculate the consequences of transduction of viral vectors into damaged 
myocardium. These would all be valid concerns that need to be considered; 
however, I also see and believe in the significant benefits that this technique may 
offer for future basic and clinical studies. In theory, overexpressing appropriate 
levels of Kir2.1, NaV1.5, and Cx43 enables once unexcitable cells to functionally 
express the three genes that are most important in the control of ventricular 
excitability and cell-to-cell propagation. It would be expected that the newly 
transfected genes should increase the excitability and conduction properties of 
the damaged myocytes themselves; and should myofibroblast-myocyte coupling 
exist in vivo, then the transfer of these genes into myofibroblasts might also  
improve excitability in the injured zone, which would thereby help prevent 
arrhythmias. As suggested above, viral constructs that specifically target 
myofibroblasts can be generated as an additional gene therapy approach. It has 
been suggested that, in combination with the development of novel delivery 
methods, gene therapy may prove to be an effective strategy to eliminate 
arrhythmias. Lastly, based on theory and the data presented in this thesis, it is 
my long-term hope and expectation that the use of transformed fibroblasts, such 
as fully mature induced-pluripotent stem cell derived cardiomyocytes, will be able 
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to restore the function lost by injured cardiac myocytes, rescue the impaired 
excitability of fibrotic myocardium, and ultimately rescue the rhythmic contraction 
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